Reference sequence (query): batch____ Identities normalised by aligned length. Colored by: property
HSP processing: ranked Search cycle: 2
1 [ . . . . : . . . . 1 . . . . : . . . . ] 197
batch____ bits E-value N 100.0% 1:197 MNEIISAAVLLILIMDPLGNLPIFMSVLKHTEPKRRRAIMVRELLIALLVMLVFLFAGEKILAFLSLRAETVSISGGIILFLIAIKMIFPSASGNSSGLPAGEEPFIVPLAIPLVAGPTILATLMLLSHQYPNQMGHLVIALLLAWGGTFVILLQSSLFLRLLGEKGVNALERLMGLILVMMATQMFLDGIRMWMKG
1 UniRef50_C6X9P4 Multiple antibiotic resista... 164 1e-39 1 30.3% 3:197 6:208 --YLFKTGIALFAIVNPVGSVPIFISATDGWSPKDRARTAKTVGLTVFVVLMTSAFLGNGILDFFSISIPSFQVGGGILVMLIAISMMHGKQSHARQTPEEaeVIAIVPLSIPLLAGPGAISSMIITAQKHSGFWGHviVPVAAVCLLIWLTLRLSSAIAHKLGTLGINIVTRLMGLILAAMAVEFIAQGISGLFPG
2 UniRef50_A3P530 MarC family integral membra... 164 2e-39 1 21.9% 1:196 196:405 ISEILFGFTGLMGIINPFGIAFLFLERTESLTEAQRAALARKVAINAFIVLLAAFFVGTPILHFFGISLEALRIGGGLAVAVAGWQMLngDTAAQPVEPRNAMARAFFPLTIPLTTGPGSIATAIALNANRTHKLSEFVLSSilAALVIWQTYSRAAFLARYLGTEGTKVAMRVSAFLLLCVGVQIMLTGFSEFLR-
3 UniRef50_D1CJ06 Multiple antibiotic resista... 161 1e-38 1 32.5% 1:197 1:206 MNFFLKALVALFTIVDPIGMAPIVVGLTAHLSPAVRRRVVTRATLIATGVVAVFALFGKPLLEFLGITPEAFSIAGGALLFLVSIDMLFGRESGARETGREaeDISVFPLAIPLIAGPGTITTVILLMDSAQGhqLAVAAAVAIVMFCTWVSMSLAFPIQKRMGTTGTLVLSRVLGMLLAAIAIQYILNGLSSFAES
4 UniRef50_A3IQE6 Multiple antibiotic resista... 159 4e-38 1 27.0% 2:197 4:207 -SEYINSFITLLAISNPIGNLPIYLGLTADKTKKQRQQTIKTASIAFAIILIVSCFMGEVILSAFGISIASFRVAGGFLIFIFGFHMLQAKTSDIHHTSEeaDSIAIVPLALPLLAGPGTISSVIVLAHKTQSLVEKlsIVIIILAILIFISYSFAHVIGNFLGKTGMNIVTRLMGLITMAMAVQFMADGLEVLFPG
5 UniRef50_Q8TW39 Integral membrane protein o... 159 6e-38 1 28.4% 4:197 11:202 ---VLKGVIELFVVVDPIGNVPALLAVTSELRPRDRVRVVHRAVAFAAVLILGFAVAGKATLDYLGISVEALMIAGGILLLRAAFGMVEGDPTGFRIEPGSHIDVAYVPLGTPLLAGPGAIVTVIVMLHRHG--RLETILACLIVMLLTLVTFRAAERLARFLGRSGIRVLTRVMGVLLAAIGVQMVLDGVSAFVRG
6 UniRef50_C1D8X8 Probable multiple antibioti... 159 7e-38 1 26.3% 3:196 2:203 --EVFKIFIALLVLVNPIGAIPIFISLTPNSTAEERQRIALTTSKAVAIVTVTFALLGETILKFLNISVGSFQVGGGILMMLIAIAMMNAKQTPTKTTRQEQEeiAVVPLAIPLMTGPGTMSTIIIYASTSHDWIELvlLACGLIAVTCYVALRAATPISRMLGQTGINIVNRVMGMVLAAVSVEVIVNGLYRLFP-
7 UniRef50_D1BXK0 Multiple antibiotic resista... 158 1e-37 1 24.0% 1:196 7:209 VALFIEVFVTLFVIMDPPGSVPVFLALTSRMTPKQRNRAARQAILVAFGVIVVFAAFGQQLLQYMGITLPALQASGGLLLLFVAMELLTGKMEEPEPAKGGAVNVALVPLGTPLLAGPGAIVATMVFVQRRLehWAAIVLAVIAVHLCVYLAMRFANTIQRILKDSGVTLVTRIAGLLLAAIAVQMIATAVTEFVR-
8 UniRef50_B5I9R7 Multiple antibiotic resista... 157 3e-37 1 29.2% 1:195 3:202 VNTFLHIFIPLFAVIDPFAALPLYMSLTTGLSETQKRKIVKEASLTAIVLLIFFAFLGIYILDFMGISIEALMIAGGLLMLLVSLEMVKEGDKPRSTKkeETGDIGIVPLGTPMLAGPGAISLVIILMSKYPTEWDSIVISIVGIIILTALIFLGSNLISKIMGEKGSRAFTRVMGLLVAAFAVQYILDGVAQYF--
9 UniRef50_Q13TQ7 Multiple antibiotic resista... 156 4e-37 1 25.6% 3:197 2:204 --DILKSFISLLALINPVGAIPFFMSLTAHQSDAERRRTIRIAAISVFCVIAVTTLLGQQIIAFFGISVGSLEVGGGIIMLLMAINMLNAqtPEERHEAEQKDNIAVVPLAIPLLTGPGAISTTIIYAAGSAHWYDRISLVAivLAAICFFSLRLAEPIARWVGRTGINIGTRLMGLMLSALAVEFIVDGLKALLPN
10 UniRef50_B6IWJ1 MarC integral membrane fami... 156 4e-37 1 24.0% 2:197 5:208 -SEYSRFIVALFAMLTPFAAIPIFLGLTEGRTDAERNRTAASAALTVFSVLAGSAFLGNAVLAVVGTSLDSFRVGGGIVLLLIALSMLNATVSAVKQTPTEADeiGVVPLGLPLLAGPGSISAVIIETQRGSGwtAIIVGSITLVCLFIWLSLRLAVPIGRMMGRTGLNIMNRLFGLLLAAVAVEIISTGLRNLFPG
11 UniRef50_A0B911 Multiple antibiotic resista... 156 5e-37 1 28.2% 1:195 23:224 LQYFVYVFTSLFIIVSPIEATMVFVSLTQDASPAERDRICVRTTLVAFSIAMVFALAGDMILRFFGITVDSLRVAGGILLFLVAIDMLRAKpqAEIEDATTREDISIFPLAIPLLTGPGTITTVIVHMGASNTLpmIVLLAICLTFGATYAILKSAEHIHDILGVTGIMVFTRILGLILGAIAVDFVSVGAWNIY--
12 UniRef50_Q2IJJ0 Multiple antibiotic resista... 155 1e-36 1 28.6% 1:196 5:206 LDYGLLVFVSMFTMMGPVGVLPPFVSMTSGLSGDEARRVARRATITALCVLLVFALGGQLVFRFFNISVNSLRVVGGIILLLVGYEMLQARPSRTKHDEPApeDIAITPLGIPVIAGPGAITTVIILMSEAHdrKAVLLVVLLGLHVLTYAMLVSAKPLLAFLGPSGNKVLVRIMGLIVMVIAVEFFFAGLKPIVR-
13 UniRef50_B5EJL1 Multiple antibiotic resista... 154 1e-36 1 27.4% 1:197 7:211 LHSALQTLIALLAILNPVGAIPIFIALTSDEDPQQRLATAKLASRAVAVVLLTSAFLGEYILQFFGISIAAFQVAGGMVLMLLAFNMLQAKSSRYRHTPEEAAevAVVPLAIPLLAGPGTMVTVIIAHHKNASWlgLLIIDILVIAGVAYAALRLAEPLSRRLGVTGINISTRIFGLVLAAIAVTFIANGLAALFPG
14 UniRef50_Q1IWE7 Multiple antibiotic resista... 154 2e-36 1 29.0% 5:197 11:212 ----LQTFLTMLVVMDPIGLAPIFIGLAGNRPSFERRRMALRASVVAGVIILCFGLFGRGLLDHLGISLSAFRVAGGILLFLIALDMVFARPSGSKETPEEgqDISVFPLAIPLIAGPGTLASIMILAGDAHGNPALLAAVFVVTflLCYLALRLSGQIARVIGVTGVHVVTRVLGVLLGALAVQYVADGALEFLRG
15 UniRef50_A0NQU3 Putative uncharacterized pr... 153 2e-36 1 30.6% 1:196 2:210 LDYYINAFATLFVTIDPVGLAPMFLAITAGMSKHDRRKVAVRATITAAGILLVFYASGQTVLNVLGISVSAFRVAGGILLFLIAIEMIFGKRQARKTETAEknELAIFPLAIPLISGPAAISAIILLSSQAPDTLAylGGVIAIILLSCMGAFLLADKIERLLGETAQLVITRLLGVLLAALSVQFVADGILAFIR-
16 UniRef50_C1CXZ5 Putative multiple antibioti... 153 3e-36 1 27.9% 1:197 8:213 LTTINKTFLTMLVVMDPIGLAPIFIGLASNRPRFERQRVAFKATLVAGIIILMFGLFGRDLLKHLGISLSAFRIAGGVLLFMIALDMVFARPSGSKETPeeRQDISVFPLAIPLIAGPGTLASIMILAGDAHGEPLLLGGVFSVTflLCYLALRLSGQIARVIGLTGVHVVTRVLGVLLGALAVQYIADGTLELLRG
17 UniRef50_C5U4I6 Multiple antibiotic resista... 153 3e-36 1 30.1% 1:196 3:205 IQYFIISFTSIFSILNPIGAVPIFISLTESYPEKERILVAKKTVIYAFSILLAFAVFGEYILKFFGISIEAFKIGGGILLLLIALDMVRGKQESKIHKReeVDEIALMPLATPLLAGPGSITAVMVAMAEAPsdRIFVILAILISIFITYLTFVFSERIIDKLGRLGTRILTRLMGLILTAIAVQMILTGYLGVVR-
18 UniRef50_O32244 UPF0056 membrane protein yv... 153 3e-36 1 25.6% 2:196 4:207 -SFIVHVFISLFAVSNPIGNVPIFLTLTEGYTAAERKAIARKAAILSFFILAAFLVFGHLIFKLFDINIHALRVAGGIFIFGIAYNLLNAKEsdEHKESKEKADISVTPLSIPIIAGPGTIATVMSLSAGHsgHYAAVMIGIAAVIALTFLFFHYSAFISSKLGKTEMNVITRLMGLILAVVAVGMIGAGLKGMFP-
19 UniRef50_B4U7Z6 Multiple antibiotic resista... 152 5e-36 1 28.6% 1:196 10:213 IYFIIKFSISIFAILNPFGALPVLVSLTKGYTKEDRSYVIRTSSIYAGLTLIFFVLFGDLLFEIFGIGLGAFQIGGGIILSFVSINMIFGQPHREreEAEQKENIAIVPIAIPLLAGPGAISTVITIASSYRSVfvLLILSILVACIGVFLVFKSVDKIVKILGKIGINILSRLMGILLMSLAMQFIIKGIQLAFP-
20 UniRef50_Q0C4W2 Membrane protein, MarC fami... 152 8e-36 1 28.7% 1:195 6:213 ISLFTAAFVTFFVLIDAPGVAPIFATLTAKGSPAYRRKMAYKSVFVATIIMLLFAFGGAWLLDAMHISIDAFRAAGGVLLFLIALDMVFEKRTERREQrpEPEDVSVFPMGIPMIAGPGSIATAMFYMTEAEshQGVVLAAIGANLLITLIIFLLATPIVRLMGASVAGALTRILGVILAALSAQLILDGIRGAF--
21 UniRef50_C1D7D3 Probable multiple antibioti... 151 1e-35 1 23.2% 4:197 11:222 ---FLFALAALLPIINPPGLIPIFLSLTSRNTREQRQFLARRIAIYGFVLLAGSMFIGSYLLSFFGVSLPVVQLGGGLLLTFTAWRMLNDTPAEHSTHAPEPEHiaFYPLGFPLTVGPGSVSVSITIGATFFHspVASLLAVAVVCYLIYFCYLHAETMLHHLGPTGAVVFLRLSAFILVCLGMQIMWNGISELISG
22 UniRef50_B2S4M5 Hypothetical integral membr... 151 1e-35 1 38.1% 2:195 84:275 -THIWSTAFTLLFIIDPIGNIPVVLSVLRTVPAERHTRIIFRELLLGLVLMLSFLFCGKVFLSLFQLETGVMKMAGSVILFLVGIKMVFPDQHALPSTTEE--EPFIVPIATPMIAGPSAFTTLVIMGETKGTSRLATCAALLVAWTLACLIMISAPCLYRLLKEKGITALERITGILLLILSIQMCVEGARGII--
23 UniRef50_C8WCE4 Multiple antibiotic resista... 150 2e-35 1 29.1% 1:196 2:207 ISLFISTCISLFVVIDVPGCAPIFASLTKNATSTEQRTMAIRAVLVSSGILVFFGFLGESFLRAVGIGLAAFRIAGGILVLLTAIEMVFEKRTQKREdpEEAEDISVFPMAIPMIAGPGSIATIMLLISKTENwrITVFGALGAIQIMMVISLILAGPIMRVLGRRAEAMITRVLGLILAALAIQFILDGLKEFFH-
24 UniRef50_D0KYA2 Multiple antibiotic resista... 150 2e-35 1 27.5% 1:193 5:209 MHHALTAFMAFLAMMNPVANAVIFLGLTADMGLATTRHVAWRAVRTAFFIVLTFALFGPLVFSLFGITLPALRVAGGVLIALVGFRMLHGENSRVSHPKqsQNDIAITPLAIPVLAGPGTIATAMSYssGHWMQTGATILMFTLICALTFYAFVFSERILARIGRGGVAVITRLMGLILAVIGVQMLLDGLHQ----
25 UniRef50_Q1GI30 Multiple antibiotic resista... 150 2e-35 1 31.2% 3:194 6:203 --FLITSFVTLFVIIDPIGLMPVFLALTQGMTSKQRRAIAIRASITGIGILAVFALFGESVLGFIGISMPAFRVAGGILLFLTALDMLFERRTARRQHQGdeDDPSVFPMAIPLIAGPGSIATVILLTGQHPggFASVMAIVVAVIALMLGMFSISGALERLLGPVGINVATRLLGMLLAALSVQFVLDGLSAF---
26 UniRef50_A7JXE2 Multiple antibiotic resista... 150 3e-35 1 26.0% 1:196 5:209 IVHTVTVFMGFFAIMNPIANIPIFLSLTADEDKETVRSMALRSVFIAFVIIAIFSIAGKLIFDLFGITLYALRITGGILVFLIGFNMLQGDSTHQKTkqQAALSIAVSPLAMPILAGPGTIATAMNFATAGGFDQTIiiVSFAVLCVITYILFLFGDKLVKAVGPSALNVVTKMMGLILAVIGTQMFIDGAGEAYK-
27 UniRef50_B9JF99 Multiple antibiotic resista... 150 3e-35 1 28.9% 2:195 5:207 -DTLINAFTTLLVTVDPPGLAPLFIGLTAGMNRAERKQVALRGSLIAFFILAAFALFGASVLGILGISIGAFRIAGGLLLFWIAFEMVFEKRQDRKEKTTeiHNIAVFPLALPLIAGPGAISATILLAGSLQTTfaQLIGVIAVNLGLVFAALAISDRLDRMLGATGRAILTRLLGVILAALAAQFVVDGVRSAL--
28 UniRef50_B5ZPR0 Multiple antibiotic resista... 150 3e-35 1 29.4% 2:195 5:207 -DQLINAFTTLIVTIDPPGLAPIFLGLTTGMSRAQRTQVALRGSTIAFIILAVFALFGASVLGVLGISIGAFRIAGGLLLFWIAFEMVFERRQERKEKATEaeNIAVFPLALPLIAGPGAISATILLAGTLPTSvaQFIAVIAANLLLTFLMLLIADRLDRFLGVTGRAILTRLLGVILAALAVQFVVDGAKAAL--
29 UniRef50_A6KWY6 MarC family integral membra... 150 4e-35 1 25.6% 1:195 5:205 LPFALLCFTSFFTLTNPLGTMPVFLTMTKGMDDEERRHIVKRATIISFITLLAFTFSGQFLFKFFGISTNGFRIAAGFIILKIGYDMLQARFTNTKLKDEeaNDISITPLSIPMLCGPGAIANGIMLMDDANTWTMKGILIGIIGlfITYLILRASTRLVSILGETGNNVMMRLMGLILMVIAVECFVSGFRPIL--
30 UniRef50_B4E5W5 MarC family integral membra... 148 6e-35 1 44.6% 2:196 3:198 -YTFLSATVLLVLITDPLGNIPLFISAMRDVPRERRVKLILREVGIAFMILLFFMVVGDRFLRMMSLTDLSLRLGGGIVLFLIALRMIFPHPDGagSDPRAGGEPFIVPLAIPALAGPSALATVMLLTSQAPGKMFEWVGALTVTMIVCAITLVLAERIQAWLGERTVAAFERLMGLVLVAISVEMLLAGIRAFVH-
31 UniRef50_O66819 UPF0056 membrane protein aq... 148 7e-35 1 25.8% 3:196 12:213 --LFVKAFLSLLAIMNPFSSVPVVISLMNEYSKEEIRVIALKASVYAFFILTFFLISGDLLFRFMGITLPAFKVGGGILLFLIALNLVQGEVTKEKGKAHerDNIALIPLAMPLLAGPGSITTVLVLRGYLNTLEGKVAlaIFLSSFTAFVVYSLSTFFYRVLGRTGINLITRISGILLLAISVQFVVDGLKNLLK-
32 UniRef50_Q11TX7 Multiple antibiotic resista... 148 7e-35 1 20.8% 1:197 1:204 MDLIFATVAALLPIINPFSTAPMFLSLTQGDTKSYRNAQATQGVIYMLAILLVSLVGGSFIMNFFGLSMPGMRIAGGILVAGVGMKMLKptTEAETKEAENKKDISFTPLAMPSLSGPGSISVVIGMsaKNISDYCYIALGIIFVACVVLLVLRSSVGLVKVLGVNGLHAMTKIMGFLILCVGIQFIIHGTMDILTG
33 UniRef50_Q1Q2V4 Putative uncharacterized pr... 148 8e-35 1 27.0% 2:197 5:208 -TEYTRFLTALMVILDPFAAIPIFLSLTQGYSQSQRARVVLVTIITVALVLISSAISGESLLKTFGTSLASFRVGGGIVLFIMALAMLRAQADkeEAAAENKATIAVVPLAIPLLAGPGSISTVIIEMHraTYHGALVILCILITCILLWIVLRLASPIGRALGPIGRNILNRLFGLILTAIAIEIIANGLRELFPS
34 UniRef50_B5JMP6 Putative uncharacterized pr... 148 1e-34 1 23.7% 1:194 5:206 LEFLLLSTVSIFTIVNPFSAVPAFLAITPGESVVERRRSARLACLIAVCLLILTAVLGEFIFSLLGITLPALQIAGGVLLFSIGFEMVRAPdeTESDLAKEKEDISVTPLAVPLLCGPGSVSTVIILQGQTTSMmsMLLVSIVVVFVACYLILSASAKGGEWLNPILMRILRRVMGLLFAVIAVQFVVNGVGDL---
35 UniRef50_Q7NGH4 Gll3195 protein n=1 Tax=Glo... 147 2e-34 1 24.2% 7:196 15:208 ------TFLALLPVTDPLGAVPIFYSLTSSGSDSYRRRQARLTTIHVLWLLAGFLLVGKVVLEFFGISFAVLRIAGGLLIAQTGWEMVNSHRHEGDTALAasGDIAFAPMAMPLVSGPGAIGVVIGLSSKASGWPDYflVGIALVAGVLYLCLMLGEPLLKRLGRAGTRALNQILGFLILAIALQFMVDGLRELLR-
36 UniRef50_D1JHZ5 Conserved hypothetical memb... 147 2e-34 1 26.8% 3:196 9:211 --FLCTCLGGYFAIMNPIANTPVFISLTQGDDAATKKAVARNSILFAFVLIAFLSFAGNFIFKLFGITQPALQITGGIIIFMIGYHMLQGSGSKAHTPSDdrLNVAISPLGIPILAGPGTIAVAMGYAAGFeiHVILSLLAFGVICGITYLCFRGSEEIVEHLGQNGLNVITRLMGLCLAAIGTGMVLSGLGADIH-
37 UniRef50_Q58382 UPF0056 membrane protein MJ... 147 2e-34 1 27.9% 1:197 20:224 LNFYIYGFVSLFITIDPIGLIPIVHSLTYPYPKEQRIRIIKKAIISSTVVLLLFALFGNYIFGYFGITIDAFRVAGGILLFKIAWDMLHAEIPKTKHKPDErdSIVYVPLAIPLISGPGAITTTMILISKTQSIlgVVVLSILSAMLVSGIILSLTDFIIRRVNIYGINAFVRIMGLLLVAISVQIIFTGIVGLYNS
38 UniRef50_D2RH21 Multiple antibiotic resista... 147 2e-34 1 22.9% 1:192 7:205 ISYFVTAFTTIFVIVDPPGNIPFFIALTERFSEKERDRVSKKSTLIACALLIIIALSGDILLKFFHISIESLKVAGGILLFVIAIDILLGGARKEFykHIDVDSLAVFPIALPLYTGPGAITATIVLSAEASdsKILLIASIALVYIIVRLTHVYSEVVIKVLGKSGSDIVARVMAIFLAAIGVEYVFSGLE-----
39 UniRef50_B9XPN0 Multiple antibiotic resista... 147 2e-34 1 25.4% 2:194 5:205 -EYTLLAGSSLFVIVDPVATVPAFIAMTPHDTPEQRIKTARLACFVMAGVLLSFAAAGRVIFKLMGITMPAFQIAASIVLLLVALDMLRAQRSRVQETHEETedIAVTPLAIPMLAGPGAISTAILLQNQAKTAaaAVYVCILGVSFASYLILKVSARGAKWLNPIAMNVAIRIMGLLLAAVAIQFGLNAFKTL---
40 UniRef50_B9NN29 Putative uncharacterized pr... 147 2e-34 1 22.4% 2:197 4:208 -TLAVGFFGALFAIMNPVTNLPVFLSVTQDLSVADQRKVAIKTATYCLILGTAFAAVGSQALSLFGISVNDLRVAGGLVVLMIGFNMLSggTDGEKESYPAADTVAFYPLAFPILVGPGTITTLILYAHHVKTTVDIFvgVFLAILALLLITFWNAAWLAKRLSANARVIMSRFMGMILAAIAISMIADGLKVLLPG
41 UniRef50_Q03GN0 Multiple antibiotic transpo... 147 3e-34 1 27.0% 1:196 4:206 VQAFLLSFTAFFAIMNPFANLPMFVSLTADNNRKEVDAIARLAFIVATVIVALFALLGNYIFSIFGINLSALRIMGGIILGLIGYHMIQGNVSPIQHDPKQstDVAISPLAMPVLAGPGTIATTMNLSSS--TNPFIVISAFVVLSVITYFIFIYGEQIMAKLGNNIMNVITKLMGLILATIGVRMLIMGVQVAFH-
42 UniRef50_C1D6U8 Multiple drug resistance pr... 147 3e-34 1 21.1% 2:195 9:211 -QYFLGAMLSFVVITNPLSKIPMFLSLTPGQTPVQKNRVAFTACAYAGAIMVVSLIGGNLVLSMFGISYGALRVAGGLVVAGVGYKMLYQAHDSTSHAHRESVDVSFFPLAMPGISGPGTIAVVIGFSTEIAeaILITLGAIGGTMLVVWLSLKLSAKIAERIGPSALDVLTRLMGFLLICIGVQFVGSGIRTFY--
43 UniRef50_Q3DS24 Integral membrane protein o... 147 3e-34 1 28.2% 1:163 2:168 ISKFILAFMAFFAIMNPISNLPAFMALVADDDQKISRRIAAKGVLLAFVIIVIFVLSGHLLFNLFGITLAALKISGGILVGIIGYKMINGIHSPTNKNLEEHKdvAVSPLAMPLLAGPGTIATAMGLSSGGLSGKLITILAFAILCVIMYVILISANEITKFL----------------------------------
44 UniRef50_B2IEA6 Multiple antibiotic resista... 147 3e-34 1 28.9% 3:196 4:208 --YLLQTFTTLFVVVDPLAMAPLFIAVTAGLTPVERRIVGRRACLSALFILLGFALLGETLLTVTGISLQAFRIAGGILLFWIAFEMVFHKRSDRKSAEVARTelAVFPIAMPLIAGPGAIAAVIVATTHAPNtfFGVIVLIIAIMAMTFVVLQIADRIDAFMGPTGRAVISRLLGVLLSALAVQIAIDGVHGLIP-
45 UniRef50_A9A830 Multiple antibiotic resista... 146 3e-34 1 29.7% 1:195 3:212 VQFIILAFTSLFSILNPFGVIPTYLVLTSQYSKVEKIKIIRKSMLAAFTILMMFALLGNQIIGFFGISIPAIKITGGVLLFLIALDMIQGNTSkhSEEIEEMNEIAIVPLTVPLLTGPGSISAVIAMMAQTndGKISVIIAISLCIIISYFVLKFSKDLERILGKIGFKVLTKMMGLVLTAISIQMALDGILMVF--
46 UniRef50_Q11II0 Multiple antibiotic resista... 146 4e-34 1 31.1% 2:197 12:216 -DAILNAFTTLLVTVDPPGLAPLFLALTAGMNRQERHQVAIRACLISLGVLVLFALAGSSILSVLGITIPAFRVAGGMLLFVIAFEMIFERRQQRHKRSAErhNIAAFPLAIPLTAGPGAISATLLLsaSAPGARLVMVAILLVVILITYLVFVLAERIDRFLGETGRSILTRLLGLLLSALAVQFVADGARELIQN
47 UniRef50_Q59071 UPF0056 membrane protein MJ... 146 4e-34 1 30.3% 1:195 3:204 LQYFILAFSSIFSILNPFGAVPVFITLTESYPKKERDLVAKKTVIYALAILLAFALFGEWILKFFGISLDAFKIAGGILLLLISLDMVRGQQEAKIHRKeeIDEIALMPLATPLLAGPGSITACMVAMAEAsgDKFLVILAILLSLGITYLTLLSAESVLDRIGRLGIRILTRMMGLILTAIAVQMIVNGIRGAL--
48 UniRef50_O28169 UPF0056 membrane protein AF... 145 8e-34 1 25.4% 1:193 7:206 LSFFFASFTTLFIIIDPPGNLPIFIALTERFSDEYREKISKRATIIAFLILFITMVTGGKILDYFGVSISSLKIAGGILLFISSVDILLGGTRReaEESIDVDSIAVFPLALPLYTGPGAITAGIVLYSQAGDVVMKLLVVLSAALviVRLSHIYSAPIIRLLGRSGADIAARILAIFLAAIAVEFVFDGLAE----
49 UniRef50_C9YF10 UPF0056 membrane protein bb... 145 8e-34 1 43.6% 2:196 21:213 -YTFASATILLILITDPVGNIPIFANALKHVAPERRPKVILREILIAFTLLLTFMFVGESFLRVMNLSELSLQIGGGVILFLIALRMVFPP--AATAETEIKTEPLIVPLAIPAVAGPSALATVLLLVSQQPDRRMEWIGALCVTMLVSAVVLVSAERIQRIIGDRLVVAAERLMGLVLVSVAIEMMLRGIKTFVH-
50 UniRef50_Q7NUG9 Probable multiple antibioti... 145 9e-34 1 23.2% 1:194 8:220 ITKFLFVMAALLPIMNPPGLVPIFISMTARNTPQQRRYLARRIAIYCALLLVGSMFVGGYVLSFFGVSLPVVQMSGGLLITFAAWRMLNDTPAESSQPSAEQARvaFYPLTFPLTVGPGSVSVAITIGATLTGSGKGllSAVLVGSTLVYLCYANADKLLRYLGQTGSVVFLRLSAFILLCLGVQIMWDGFGEL---
51 UniRef50_A5FN26 Multiple antibiotic resista... 145 9e-34 1 25.4% 1:197 23:228 MDLFIYLFAALFSVLNPIGTVPIFVGLTQHDSQKERSRISLWTAINVGIILLVSYFIGQYVLTFFGISIDALRIAGGIVIVNSGFSLLSGknKKIENEVQQRNDIALTPLAIPMLAGPGSISLLIAFYQEHHQMEEILflAILAIAVVIFVILKSAHYLARILGASGIVAISRIVGFIVISIGIQYIVSSIVNIIKG
52 UniRef50_A8HXT9 Multiple antibiotic resista... 144 1e-33 1 22.8% 1:197 5:222 INIFVAVFAALFPIVNPLGGAPIFYEMTRACAPQVRASLAMKVAIYGFILLVVSLVAGSRILTFFGISLPVLRVAGGLVVTFVGWNILHQGDASAEKAPDAteQQAFYPLTMPLTMGPGSIATAIALGSqyGHMIIEAMGaiAAVSASVYFAYRYASDIERFLGPNGTNVLVRLFAFILLCIGMQIMWLGIRDLVAS
53 UniRef50_B1ZWU7 Multiple antibiotic resista... 144 2e-33 1 21.1% 2:195 9:209 -ELILGTVIALLPLINPLASAPTFLAITDGDTPERRNQQLRMACLYTVGILVSFLIGGTFIMGFFGLSIPGLRIAGGLLVAGIGSHMLMSPPKPATDDPVHAadISFSPLAMPMMSGPGSIAATISFTSLARGWIDYviLGIIIVTVITYVTLRISDRVVRVVGFNSMNALSQVMGFLILCIGIQFVVNGVTEIV--
54 UniRef50_Q0W3L9 Putative multiple antibioti... 144 2e-33 1 30.3% 2:196 10:208 -TLFIHALVGVFVIVNPFGNIPIFISLTSKLTPAERRTAIIKSLLIATAILLVFALIGQAVFTLLNVTLPSLRIAGGLLLLAIAFDMLMGRSPASkdESDEREAVAVTPMATPLLAGPGAMSTVMILMNEAATnkLSIFLAILLAMGAAFLILINSELLYSVIKKDGSRVLTKIMGIVLATIAIEMMVNGLLKAFP-
55 UniRef50_UPI0001746B52 hypothetical protein VspiD_... 144 2e-33 1 45.1% 2:196 4:197 -TDWISALVLLLIVLDPLGNVPVFSSLLRQVEPARRKRVILRECGIALVVLFLFLAFGGGFLKLVGLSQSSLGIAGSIILFMIALRMVFESTEKVFGGLPQG-EPFIVPMAIPMLAGPSALATVILFTTREGISTLGAVGAISIAMGVTCIVLLLGERIIRLVGERGLAAMERLMGLLLTAIAVEMFLRGVKEFMK-
56 UniRef50_B6R883 Putative uncharacterized pr... 143 2e-33 1 25.1% 2:196 24:225 -TALITYVAALFSMMNPIGNTGVFAGMTADRDAATARRIAWTCAGAIALTLLTVTWTGGILLKFFGITVHELRAAGGVIVLLIALSMLRSDNSHRQTPQeeQNHIAVVPLAIPIVAGPGAIATAIVAAERHSGIWAKIDLSIAAvaLFTGFLFSVSKPIANKLGESGMGVVTRLMGMVLAAIAMGMLADGVKGMIP-
57 UniRef50_Q0A888 Multiple antibiotic resista... 143 2e-33 1 27.9% 1:197 5:211 LEYLIITFVAVFVIVNPLTTSFVFMALLPTASARRRRTIARRATVIATALFFLFATLGGLIFQIFGITLAAFRIAGGLILFGVAMAMIRQTLPSEAETAEQadDISVIPLAIPFISGPGAIATVMILTSEAPthLALVYLAVLSCTVTCYFAMIYSRHIVRFLGDTGKEILTKIFGLILAVLAIQFVINGVSDAVTG
58 UniRef50_B8F4B7 Multiple antibiotic resista... 143 2e-33 1 27.3% 2:195 3:201 -DSLVVQFVVLWAVIDPIGSIPVYLAKTVGLSPEDRRKIARNAILIAAGILLFFLVLGQWLLDAMQIPLSAFQIAGGLVLLLFALTMIFgkPDQEIKMKSNLHELAVYPLAVPSIASPGAMMAVVLLTDNHRYSFGDQVItmLSVLLITYILFLVANRIQHFIGHAGAAIISRVMGLILSAVAINNILLGLKDFI--
59 UniRef50_B5EBI8 Multiple antibiotic resista... 143 2e-33 1 31.1% 1:196 9:212 MEQLIVFVVQLFVIVDPLAAVPIFLAITVSHTKQERRSIARRGCSIGLLAIVFFLVAGPSLLRYFAINTSAVQISGGLLLFVIALELLYGNPTGTQTSSKekEDVSVTPLAIPLLAGPGAIVTCLVFSSQASdsVLILIGGAVIVFSAAYLLLHWADELARIFGELGMKVAVRIIGLILAFIAVQYVINGITALWP-
60 UniRef50_B6JA04 Putative membrane protein n... 143 3e-33 1 22.4% 1:196 8:216 VNAFLLVYAALFPVINPVGGAPIFLRLTNRTPKARLPSLARGVAINSFVLLLCSLFIGSHVLVFFGITLPVLRIAGGLVVAALGWRLLHQGDDLEGRDQPAPREkaFYPLTMPLTVGPGSISVAITLGSQRPSsgGGAATGLAAIAATIYVCYRFAGNIVTVLGERGTNVMMRLSAFLLFCIGIQIIWGGLRTLLP-
61 UniRef50_Q8DGX4 Tlr2188 protein n=1 Tax=The... 143 3e-33 1 24.0% 1:196 5:205 LTFLLGTIAALFPITDPIAAIPVFYALTAKQSRRQRLKQARQVAINVAAVLTVFFFMGKLILAFFGISLPVVRIAGGLIVGHTAWQMVTSQDRLTQQEHIEAadISLTPMAIPLISGPGAIAMTISLSTRCHTWLEYlwLGILLLSAMVYLFLILGEPLSRAWGITDRGALTRLLGFLILAIAVQFIADGSLALLQ-
62 UniRef50_A9NB13 Membrane protein, MarC fami... 143 3e-33 1 39.9% 3:195 2:192 --TLYTIAITLILVMDPLGNIPVFLAILKQYDARTQVRIILRESIIAFFILALFVFFGRYILHGLHITTPALSIAGGVILFIIAIRMIFPPDQKP--AKEDFEEPLIVPLAIPLTAGPSAMAMVLLFVTRDPHHLWLIFLGVFIASLIFTLIMLWAPYLIKILGKRGLTAIERLMGMILTTIAVQMFLAGIAEYL--
63 UniRef50_Q1IU42 Multiple antibiotic resista... 143 3e-33 1 25.3% 1:194 10:210 VQFTLVALSSVFFLVDPFAIIPTFLVMTARHDPITRRRMAARACWTAFIVLTAFAFAGTAIFKIFGITLPAFEIAGGLILLLIGLDMMQAERPTQEGSPETAedVSITPLGIPMLAGPGAISTVMVltARDWSTTIPVFAAIALTCFASYWILRGAERVSQKMGQTGIRVLMRIMGLLLMAIAIQFMINGLTNL---
64 UniRef50_A5WGW0 Multiple antibiotic resista... 143 3e-33 1 26.0% 2:197 3:211 -TEIVKIILAFVVLINPFSALTLFLDSTRGYSMTDKRRFARISSLTVFITIAFFTVAGETLLKVLGISVGSFQIAGGVLVFLIAINMMNGEGNPVKPNQENVeaAAVVPLAIPMMVGPGGISTVIIYSAQVTGWqlAIIIAGLLISIFCYLALMAAGQLSRFLGDTGLNIISRIMGMLLAAVAIEILVNGIKTVFPG
65 UniRef50_D1JFE0 Membrane protein, MarC fami... 143 3e-33 1 22.9% 3:194 5:203 --YAVSVFIAIFAIVNPLGNIAFFTTLTQDYSKAEKKKVATKAIIAATATLIIFALVGRYIFVLFNITIPAFRIAGGLLLLMIAFSMLYgsTEKEKQESVEKEMVGVIPLGIPMLAGPGAISTVMLYISHGNIwaLIVFISVFATMAVTYIFLANADRIFNRVGRVGSLAISRIMGLILATVAIQFLINGTHEI---
66 UniRef50_Q1H467 Multiple antibiotic resista... 142 5e-33 1 27.2% 1:195 7:213 LKYISIVVIGLLPIMNPLTTIPLYMALTQRMTPETRKLQARKACIYAFFILTTFLLLGNGIIALFGISMAGIRVAGGLIILILALRMIFSGLDSSSSVDSEPEEisFSPLAMPSLAGPGSIAVVMSFGSQIPEGspIVIAGIAITIGIAYLALSSATHIEKMLGEHGMQAVTKIMGFLLTCVAVQFLASGIRDFY--
67 UniRef50_Q2FNQ4 Multiple antibiotic resista... 142 5e-33 1 23.0% 1:196 6:212 ISFSLFALSSILIVVNPLGALLVYNSITEFMDSKDKRKVAAYGCRIAGAVLIFFTLFGSSLLSLFGITISAFTVAGGVLLFGIGMEMVYARTstEKYESIDAEDISSMPLAFPMISGPGTITTVIVLSQDTPieLGIILGSVIVTILITYIVLISSEQITKRIGQREYRVVNRLMGIMLMAIAVQFIINGISQAFP-
68 UniRef50_A0KDA2 Multiple antibiotic resista... 142 7e-33 1 28.2% 1:195 29:232 LTFSIKVFAALFAIMNPIANIPVFLSLTEGAADGVRRKVALTAAIGVTVGCIVSAVAGGAILHVFGLTIDDFRLAGGLLVLLIALSMLHGAPsdESADPAAADSVAIYPLTIPLLVGPGTIATMIVLGHGAVATGQEFAFALGLAAflLAVSLLSAPLIGHYLSPRVTAVTQRLMGMILAAIAMQMIVASLKAAF--
69 UniRef50_Q2SQZ5 Multiple antibiotic transpo... 142 8e-33 1 49.2% 3:195 2:193 --DIVSALTLLIVVMDPLGNIPLFLSILERVDVKRRKKVLFRELLIALAILLVFLFCGQYLLKIFSLSKESVGIAGAIVLFIIALRMIFPAKREWLEDLPDG-EPFIVPLAIPFVAGPSALATLILISTREPERMMDWSIVVLLAWSVTAVTLMSSTFLYKVLRKRGIIAIERLMGMLLIAVSVEMFLTGLQPIL--
70 UniRef50_B0C1W1 Multiple antibiotic resista... 142 9e-33 1 27.9% 1:197 4:214 LPEYLKLVAGLASIVNPVGVIPIFLSLTEGQGSSQRRLIAFQSSIALSIVLLVALVAGEAILSFFSISLPSFRVAGGLLILLTALSMLRAETIESRQLTETgaPVAVVPIAIPLLGGPGAISTVIVYAHTQEshTILVGLAILSVSVIALVGLLIAPLMDTVMGKTGMNVISRVMGLIITAISIEFIADGVKELLPG
71 UniRef50_Q26F85 Multiple antibiotic resista... 141 1e-32 1 20.5% 1:195 5:203 LTFAFTVFTGFFAIMNPISNMPIFLTITEGADKETKQRINLKAIIVAFIIVSTFVLLGNYIFELFGITIPAFKITGGILIFFVGFEMLQSKKSNIKRLKTVneNIAISPLAIPILAGPGTIVTATNFVANTSsdIAVVLLVFALMCLLNYIAFSLSDVIAKKIGDNVISVIGKLMGLIIAIIGTSMIISGLKLSF--
72 UniRef50_A8FYJ7 Multiple antibiotic resista... 141 1e-32 1 27.5% 3:195 7:216 --HLGTVFMGFFAIMNPIANVPIFLGLTSEEDEQTTKAIAFRALLLAFIIITVFALMGQFIFTLFGISLSAFRITGGFLVFLIGFHMLQgkAKSGDTQREAALSIAVSPLALPILAGPGTIATAMSFSAVGgaEMLITIGTFGALCVVTYLFFIFGGRLVNYLGSAALGAITRMMGLILAVIGTQMAIEGIKGAF--
73 UniRef50_Q89AB7 UPF0056 membrane protein bb... 141 1e-32 1 71.8% 1:195 1:197 MKEIISVTILLILIMDPLGNLPIFMSILKHLEPQRRKKILIREMMIALLIMLLFLFAGEKILIFLNLRAETVSVSGGIILFLIAIKMIFPtsKKKSGNIIKREEPFLVPLAIPLVAGPSLLATLMLLSHQYPKKILYLIGSLLIAWMITVVILLLSDIFLRLFGSKGVNALERLMGLILIMLSTQMFLDGIKSWF--
74 UniRef50_C1DAG1 Probable multiple antibioti... 140 2e-32 1 20.1% 2:195 10:219 -SKVLFVIAALFPILNPPGHAPLFLSLTVHNTPEERAILARKVGIYSFMLLLPSMFIGSYVLRIFDITLPFVQVGGGILVAIAAWEMLADKHGPSPEEQAEPHQlaFYPITFPITVGPGSITVAITVGASMQglPLASFVAVSLIAYSLYWSYRYADRLLRLLGPNGTMVFLRLSAFILMCLGVQIFWEGLTQLI--
75 UniRef50_B4WGQ9 Putative uncharacterized pr... 140 2e-32 1 28.6% 2:197 8:219 -DFILGSIAALFPVMDPIGSVPVFLVLTAGVPQSLRHSYARRIALNVIFLLISFLLVGGGILRFFGISLEVVRIAGGIVVFHAAWNTMNAESkdAAQKAGEHKDISFMPMTIPLLAGPGSIAVVLGLAAEASRGAGTVETAQNLLAVviYVALRSSSLLLKWLGAGGIQALSRLLGLFVMAIGVQLILSGLGDWIES
76 UniRef50_Q3SRM8 Multiple antibiotic resista... 140 3e-32 1 26.8% 2:195 4:206 -DYALTTFATLMVVVDPIGLAPVFLSITQGLPKAARRGIGWRASAIAAAILVATALGGTWLLARLGIGLPAFRISGGLLLFVVAFEMVLgaQQATQAAEEHARNIAAFPLAIPMIAGPGAITATLLLAGRAADQpiALIAIIIAVAAICGVTFALAGRVAGALGHTGNVVLSRLLGVVLAALAVQFVIDGIREAF--
77 UniRef50_A7HDJ2 Multiple antibiotic resista... 140 3e-32 1 28.4% 1:197 18:224 LSLGFVSFSAIFFVVDPFSAVPFFLAMTRRHSAEERRVIALRASIAAGVVLAGFALAGAWVFKLLGISLGAFKIAGGVVLLLLALDMIRTQPSRTreAGADKEDIAIVPLAMPLLAGPGGIATAVVLMARARGGPWwvLVAIALTAAASYAILAGATRTEKVLGRTGLAILERAAGLLLVAIGIQFMLDGLSESFVG
78 UniRef50_A2BM88 Predicted transporter prote... 139 4e-32 1 27.8% 2:195 10:202 -ETLVQSIVLLFIAIDPIGNAPLFYSLTARLDARLRVRIVKQSCIVATSILFVFALTGNTALSYFGLTLADFRIAGGIVLLIYGIAGILGWTEAEmrHPEEVESIAIVPLATPLLAGPAAIATVLYV--RAVHGLTYALASVTVNTAITFLMLYHSQKLMNLLGKNGAIALSKIMAMLLAAIAVAMIRTGIQDIL--
79 UniRef50_A4SSK7 Multiple antibiotic resista... 139 4e-32 1 23.1% 13:194 15:204 ------------PMVNPPTTATLLLGLSKGMSREHVRRQVNLAAIYLFFTLCITFFIGSSILDLFGISIPGLRLAGGLIIGFIGFRMLFPAPSQTN-GVDINQSIAFVPLTMPSMCGPGTMALVISGAAQIatIYGAMVTAFALMSLISWGVLKLADPVCKILGATGIDAMTRIMGFLLVCMGMQFCINGIKEV---
80 UniRef50_C6BVR8 Multiple antibiotic resista... 139 5e-32 1 24.6% 1:195 2:197 LALFFQTYLKLFFVLTPFFAISAFLSLTQEMSPAERKKTAVKVTVAVIVSSVILYLYGRYIFDVFGITLDAFRIGAGAVLFLSALNMVNGGGKKFDAGKDD-DDIAVVPLAIPIVVGPGTIGALLVMGSGVQGYKDMFLaaLVAAVLTVGILLFISSSLKRLLGKRGLNIMSRLTGLVVASIAAQIFFTGLRNFM--
81 UniRef50_A5W9L0 Multiple antibiotic resista... 139 6e-32 1 24.1% 1:195 2:196 LHELFSVYLKMLVLYSPFFVLSCFISLTRGHSSKERKQLAWKVAFAALVASVMLYLFGRAIFGIFGITADAFRIGAGSVLFISALGMAQGKPAVQADNVQQ--DVTIVPLTIPLTVGPGTIGALLVMGVSQPHwkLLAIVSIALASFTVGLVLYLSHGIERILGDQGLQIVSRLMGLFVCALAAQIIFTGIKGYL--
82 UniRef50_Q6L1H0 Multiple antibiotic resista... 139 6e-32 1 26.2% 2:196 5:208 -YLFISSLVTLFAIMNPIGAVPILIALTDGYTKDERNNVILKSVFTAAGMMLGFMLIGVYIFQVLRISIYDFEIAGGMLLFKVAFDMLQGRTSpeKEESVEREAIGVAPLGTPLLAGPGTITTAIIFFNGNGNAifVVIMSVIILIILTYIILKFSIPIFARLGKTGSIVITRIMGLLLASIGVQLVASGIINVFH-
83 UniRef50_Q21G51 MCP methyltransferase, CheR... 138 7e-32 1 30.1% 1:196 1:202 MIDYLAVFITFFAVIDPIGTVPVFIAVTREYDQKTKRRIALLATIVAACVLLFFVVIGEIILKALSIPLSAFQISGGIVLFLFALNMIFGDSKPEEelEDDHKDTAIFPLAVPSIASPGAMLAAVLLTENAIFSLFEQvvMMLLVLVVVYILMLLSGFITRFIGTSGASVVSRVMGLILSAIATTNILTGINEYYQ-
84 UniRef50_Q8K9B4 UPF0056 membrane protein BU... 138 7e-32 1 70.1% 1:197 1:196 MNEIISTTILLILIMDPLGNLPIFMTILKKLDAKRRRIVVIREMIIALIVMLIFLFVGEKILTILNLKTETVSISGGIILFLIAIKMIFPSDEGNNGTSSE-EEPFLVPLAIPLVAGPSLLATLMLLSHQYLHHMPYLVGSLLIAWFFTIIILLLSGLFLKLFGDKGVNALERLMGLILIMLSTQMFLDGIKAWFKN
85 UniRef50_Q0AE03 Multiple antibiotic resista... 138 8e-32 1 25.6% 1:195 5:204 MDQYIQAIVALLAIANPLSAVPVFLQAVDGLDRTQRRKSALLAAISVFTILFVAAVAGNWMLDIFGISISAFRCGGGLVILLMGLTMLQGRTSSVQQEsnERRSKIFVPIAMPLVAGPGAITTVItlAEPYWKNLSVALTAIVVLTMVLWVVLLLSQGVQGLLSPLGQKILLRFFGLILVAIGVQFILAGAYEFF--
86 UniRef50_B9M3N7 Multiple antibiotic resista... 138 8e-32 1 47.7% 3:195 2:193 --TFYAAVILLLLVMDPLGGIPFFISALKNVPEHRKKKVILRELLIALALMILFMFQGTKILKMLSISGPSLTIAGGIILLLIAIKMIFPSKDEFMENVV-GNEPLIVPLAIPYVSGPSALITVTLIMSREPHRWKEWLLALLFAWVVTGSILIMCTELERLLGERGVIAIERLMGMILTTIAVEMTLNGIVAFL--
87 UniRef50_Q0W501 Conserved integral membrane... 138 1e-31 1 26.2% 2:196 4:209 -ELFVSAAISIFVMSDPFGNIPIFLSLTGGMNRPQRRRVITKASIAATVIIFIFAVVGQPAMNLLGISLNALSIAGGMLLLLIALDMLMssTENTTHEDEEADSIAITPMATPLIVGPGVMAATVVFMNRAAgdQALVLSAVLIAMLGSWIVMVNSDLLYAILHRDGTRVLTKVMGIILAAIATEMMISGLLNAFP-
88 UniRef50_B2KEY3 Multiple antibiotic resista... 138 1e-31 1 30.1% 2:197 4:215 -SFLIGAFVGTLSILNPIGNVPIFLEHVQTDSPKMQRAIALLLGLSIFALLIFFFFIGRSALNLFSITIPAFRIAGGILILLVGIRMMQGKSKFSNEGIQAalSSIIVPVAMPLFVGPGTITTVILFSDNTKTLLNTvvLVLAICSAIVTICLLSSRYIYKILGNNGMQIVVRFMGMILCAMAVQFMIDGFAQLLPG
89 UniRef50_A5FZ91 Multiple antibiotic resista... 137 1e-31 1 32.7% 1:196 6:210 IADFLYAAVALFVIIDPVGTAIIFAALTTHDDAAKRRTIAKRASAISFLVLLVFGLAGEKLLRLLGIGIPALQIAGGALLFLSAKDmlRASSEERSAASESTEDISVFPLAIPLIAGPGGMTTMVLLHAKAGGQPgaNALALAAMIAATLVSMLGARRLARLMGATGASVVGRVLGILVAALAAQFIIEGTQAALH-
90 UniRef50_Q2RH58 Multiple antibiotic resista... 137 2e-31 1 31.3% 3:197 4:207 --FFLHAVVSILAILNPIGNLPIFLSLVEGEATADQIATARRATLAAFGFLTLFVLLGNNILLFFGITLAAFRVAGSIILFSIGYKILQGRNIHSRSLAPdrDDVAITPLATPILAGPGSITTVMLLVGSEwrTILLTVAAIAVVTLGTYLIFRYATLITRHLGPMEMNIISRVMGLLLAVIAVQMGASGLLELFPG
91 UniRef50_Q164H0 MarC family integral membra... 137 3e-31 1 31.8% 3:194 7:203 --FLITAFVTMFVVIDPIGLAPLFVALTHGMSDEARRRIALRATLIAVIILLAFATFGEALLTFIGISMPAFRVAGGVLLFLTALDMLFERRTkdRSEEDDSDDPSVFPLAIPLIAGPGSIASVILLMGQRPggAVMVLGATGLVMLIVLAFFLISGPVGRALGKTGITVVTRLLGMLLAALSVQFVLDGLAAF---
92 UniRef50_Q12Z49 UPF056-domain protein n=2 T... 136 4e-31 1 21.8% 1:197 4:208 VSYFINSFITLFVIVSPITGVITFITLTNGLSLREKNVIAKKSVTLAFIISMFFIFTGTIILDVLGISLDSLKVAGGLLLLTVAFDMMHAktDKEINASYERDDIWIFPIAMPILAGPATITTAIILTETAeqQKMLLILAAVITYSVAMVTFLFSRRIHKKMGYNGMLVLTRLFGLFLGAISVDMIASGVWGLYMS
93 UniRef50_A1SUP4 Multiple antibiotic resista... 136 5e-31 1 26.9% 2:194 4:196 -TAYLHALTALFVIIDPIGAALIFNSLTGDCAKKHRTVMAVKAVLISGVTLILFGNYGEALFGHLGININSLRISGGLLLFYTAFNMV--TKATGIMSASNSDDISVYPMSIPMISGPGTLTLSILLFSHTTELSGKLAvaIISILALTLVCMLVSKYLKKIIGKTGDEILKRFFGIILAALAIQFIYDGIKNI---
94 UniRef50_B8GMF3 Multiple antibiotic resista... 136 5e-31 1 27.7% 2:189 3:199 -ETLLAAFVLLFIVVDPIGVAAIYAALVQGADRREQKRIARNGVLLATGILLTFMLLGNGLLAMLGISIPAFRVAGGVLLFILSLDMIFARQskEQREAVRSQDISVFPLAFPLIAGPGAMTTVLLMASSGHDALVllMGVVLLVLALALIALWFAPVIVRGLGETGINVVNRMLGLILSALAVQFILD--------
95 UniRef50_A8AGR9 UPF0056 inner membrane prot... 136 5e-31 1 23.8% 16:196 20:218 ---------------NPLTTVALFLGLAGNMNSAERNRQSLMASVYVFAIMMVAYYAGQLVMNTFGISIPGLRIAGGLIVAFIGFRMLFpkSKSEELEDEPSANIAFVPLAMPSTAGPGTIAMIISSAStfPGWVILValIFLAVSVILWGSLRSSGAIMRLVGKGGIEAISRLMGFLLVCMGVQFIINGVLEIIK-
96 UniRef50_Q11V88 Putative uncharacterized pr... 135 5e-31 1 19.9% 2:197 6:207 -SFALVVFTGLFAIINPIGNAPIFISFVDHLDKHQQKAIALKSVTVGFIILAIFVVFGYALFNVFNISIQAFRITGGLLVLKVGFDMINSKPKDAATLVKNSEafAISPLATPILVGPGTLSTAVSfvGNKIENSIIIICSSAIILTITYFVFISSTTLIAKIGKEALNVVTKIMGLLIASIGIQMIITSIEELIHN
97 UniRef50_B2JWZ3 Multiple antibiotic resista... 135 7e-31 1 19.4% 2:197 21:232 -ETVLLVVAGLFPVINPPAAGFIVLSLVPHATEKERAFLARSISINSLVILLVSLSIGAYVLSFFGISLPALRVAGGLVIAFAGWNLLHEQADTDREPDQAPasKAFYPLTLPITVGPGSIAVAVALGTGRpiHLAGVLVALALLWASIYLCVRFAANLEKLLGPVGTEIAMRLFAFVLFCIGVQILWLGVDDLLES
98 UniRef50_B8GXJ6 MarC family integral membra... 135 8e-31 1 28.1% 2:197 5:217 -NLAVNFFVALFALIDPIGNVPLFAAATLGAAAAGRRMVAVYIGLFMAAFLIFFYFTGVGLLEFFGISMPAFRIAGGIILFILGLDMVRDDFTTMFADAAEGieRLIVPFAMPLLIGPGSISTVIIYAAEAKdgMGIGVAVIAAVSLVTVLTFWASPLVSKVLGRIGMSIVVRVLGLILCALAVQFVLVGVADATRG
99 UniRef50_A3JXR0 Multiple antibiotic resista... 135 8e-31 1 30.0% 2:191 6:201 -SALLREFITLFVVVDPIGTLPVFYFATARVPQELHWKFAVRAVLVAWVVLIAFLVAGQWLLEGLGLRFGSFQIAGGIILFLFALTMIFGESKAEHEIEEAAREhaVFPLAMPSIASPGAMLAIVVLTDNHAHSvlMTAGLLTIVLILTLLLLLLGAQLKRVLGSTGASVVSRVMGIILATVAVDAVLGGL------
100 UniRef50_A3CST1 Multiple antibiotic resista... 135 8e-31 1 24.0% 5:196 15:204 ----LVAVASITAVMNPASTTAVFTALTEGMTPDERRQVILTTVRISFIVLAFFALTGQLVFSIFNITVPAFQIAGGILLVTVATGML--GSRGESYQAGDLENIAIVPLAFPLSCGPGTITAVILLTSAGASSLIAVFLGIAVALVISYVGMLYGPRIFAFIGEGGLRVVPKLMAVIVLAIAIQFIISGIAEAMP-
101 UniRef50_Q464W8 Multiple antibiotic resista... 135 1e-30 1 24.5% 1:196 6:209 IGFLIHVFTIIFVVVNPISGVVTFISLTSKMRDEEKNEIAKKSVILACVIALFFAIAGDIILNLFSISVDSLRIAGGILLFSIAFDMMHAktEEEISHSQEREDIWIFPISLPLLTGPGTISTVIVLMGGTGAIviIILVSITLAFIICYYIFQFSRMIHKLIGYNGMLVFTRLMGLLLAALAVDLIVKGILNIYQ-
102 UniRef50_B1Y4J7 Multiple antibiotic resista... 135 1e-30 1 40.1% 19:195 20:196 ------------------GSIPIFISVLKGVAPERRTRVALREALIAFSVLAVFMVSGQHFLTLMRLSERSLEVAGGVILIIIAIRMIFSGGSEIYSQDGEPREPFIFPLAVPLLAGPSAMATVLLLASRQPDRLLDWAGALTAAMAICATVLLLAERIRKLLGDSMVSAIEKLMGLVLTAVAVEMILAGLKRYF--
103 UniRef50_B1L4D5 Multiple antibiotic resista... 135 1e-30 1 28.9% 1:197 3:202 IEEVGISAIQIFAILNPISVIPIFLSLTEGRDEGEVRRIVGVVSVAIFIMMSIFSLAGELILKLMGISVRGLKIGGGAILMVLAVDMLQGMP---RTKSVEEEELAIVPLSTPLLVGPGTMTTILLLSNKYSGTYgiLTLASALVTVASYLILRNSGKLRKVLGVNGLRGLGRFMAIIVAATAADMISSGILDFIKS
104 UniRef50_C7RRV2 Multiple antibiotic resista... 134 2e-30 1 24.4% 1:197 5:209 LTLFISLFTTLLAIINPLEAIPVYLGLMENRPESEQRQVARRACFYATLLSFFFLIFGTLLLRVFEVPLSMVRVVGGVILTRVGFELFAPPPSGGLIPRSGGndVAFVPLAMPIMFGPGAIATLISMASTIKQSAEELilAIIACLGTTYISLIYAKPILRKIGTQGIDAATRIVGFFVAAMGMGLIFNGAVEFLES
105 UniRef50_C5BZ38 Multiple antibiotic resista... 134 2e-30 1 26.2% 1:195 7:203 VTLFSTTFLTLFVIMDPPGTVPVFLALTSTMTAKQRARAALQAVYVAFGVIMAFTLFGQAILRFLHISVPALQASGGLLLLLVALELLTGK-AEEPQPSGRGVNVALVPLGTPLLAGPGAIVASMLAVQQGDgsWVAIIAAIVLVHVSLWIAMRFAGVIHRVLGEGGTTLVTRIAGLLLAAIAVQLIADAVRAFV--
106 UniRef50_B4ETK1 Multiple antibiotic resista... 134 2e-30 1 22.9% 21:195 28:219 --------------------VALWLGLSGNMTKEQRNQQSFMACVYIFIIMTIAFYAGRVIMTTFGISIPGLRIAGGMIVAFIGFSMLFPHteKNPHRNPQAPNIAFVPLAMPSTAGPGTIAMIISTAASIPSRTDIaiTTFFLISLIVWLSLRGSTGIMRYLGHSGIDAISRVMGFLLICMGVQFMINGVLEII--
107 UniRef50_A6UWA4 Multiple antibiotic resista... 133 2e-30 1 27.3% 11:197 18:212 ----------IFIIMNPIGLVPLFYIWTSESEKTEKIELLRKSAIAVMLTLLTFALFGGSIFKFFGITLDSFKVAGGILMLKIAWDMLHAQVSKTreEPISLEDIAVVPMAIPLLAGPGTITTSIILMEHSITTYDTLIisIILATLISVVILYLSDNIARILRVSGIKAIVRIMGLILAAISIEIISSGVFGLIKS
108 UniRef50_C0DXR4 Putative uncharacterized pr... 133 3e-30 1 24.0% 1:196 2:208 ITHILYLFTGLIVLNNPLIALGYFVDKTAGFTLKEQRKTARLVSISAFICMVVAGVIGTPLLKVLGIGIPAFQIAGGILVFVIAMSMMGGEDNPVKPnpEKQFAFAVVPMATPIIVGPGGFSIVIIYSSHVGTWQgeLLIACFMVGVTCYLILAGSARLSKILGNVGIKIINRVSGLLLAAIAVEIVLAGLRSLFP-
109 UniRef50_C6E1T4 Multiple antibiotic resista... 133 3e-30 1 23.1% 2:196 6:200 -EFFFTVWIRFFFLLTPFFVLSTFLAMTPELSASERRATALRVTLAVLIACFVLYSFGNTLFSLFGITLDSFRIGAGSLLFLSAVHMVQGDDSAPPSEKRGA--ISVVPLAIPVTVGPGTTGALLVMGAEVQHNWQVFVgaLAAAVLCVGILLVCASFIEHIVGKKGITILSKLTGLFVAALAAQIVFTGVRNFLQ-
110 UniRef50_B3EKF2 Multiple antibiotic resista... 133 3e-30 1 24.6% 1:195 5:206 LSHTLVMVGGYFAIMNPLANTAIFTAVTAGMDDRGIKKTALSAVVTALCIVLCFILLGRIIFDFFGITLPALRVAGGIMVFFIGFDMMHGRtaGGGASGTPGQNLGISPLGIPILAGPGTIAVSMSYSATGNgdIAVNALVFSVMCLITYVFFLLGEKVEQKLGREGLKVITQIMGLILSVIGVQIGIEGIFGAI--
111 UniRef50_B8ELV6 Multiple antibiotic resista... 133 4e-30 1 26.3% 3:196 7:209 --LFLSTFATLLAIINPFEALPIFLMLLEGKDLSEHRRVAARATLYATLLLFFFLIFGSLIMQLFGVPLSMVRIVGGIILVKIGFELFSPSPNGGsdASSKTANFAFVPLALPIMCGPGAIATVLGMQseHIGRFAATSLAILCAMFVTYLCLAYAGKLVDKLGPMGIDATTRIVGFFVSAMGVGLVFNGVLQGLH-
112 UniRef50_C7JEW2 Multiple antibiotic resista... 133 4e-30 1 18.0% 1:194 19:230 ISSFLLAFPALFSIVNPFGAALIFAQATAGRSQTEIMALARLVSFYSLCLIMASLWLGSMVLAFFGITVNALRVAGGLVVAVRAWDLLQSPETVEAQKEKQaaDAAFFPLAMPFTVGPGTIAVAIALGSGCPADEPFWalAGVCVVAIVWAAYSGADKLVSMLGVTGTRIVSRMAALVLLCIGVQILAAGVQGF---
113 UniRef50_Q0FG46 Multiple antibiotic transpo... 133 4e-30 1 33.7% 2:194 3:200 -ELFVTAFVMLFLVIDPIGLLPIFISLTLGNN-KNRLKIGLRACSVALGILLLFGLLGENLLSFIGIGMPAFKISGGLLLFLTAVEMLFSKRGQRREEQTehDDPSVFPLATPLIAGPGSMATMILLLdsGVTSTLVVLSAMISVVFLTFIFFSLGGPFERLLGKTGINVITRLMGMLLAALSVQFVVDGLNGL---
114 UniRef50_A4SWC9 Multiple antibiotic resista... 132 6e-30 1 22.4% 1:196 6:219 LASFVTVFAALFPVINPLGDGPIFLNMVQGCSEGVRNKLARSVSVNCFFMLLASMLIGPQLLLFFGISLPALKLAGGAVVIAMGWNLLNQKSASDKGANEssDGSAFFPLTMPLTVGPGSIATAIALVAAYQEsvIGTVAALFALSLTIYFIYRESSGIQRIFGVNGTNVLMRLFAFILLAIGVQIFLGGINGYLE-
115 UniRef50_C6XRN8 Multiple antibiotic resista... 132 8e-30 1 31.0% 8:194 10:201 -------LITLFVVIDPIGTIPIFIAVTAGMAPENRPKVALIGVLIAAIVLYTFLILGQLVFEALGLALGSFQIAGGIILFLFALQMIFGPSKPEEeqAKSISQSAVFPLAMPSIASPGAIMTVIILTDNHGHSVLetAGLLLGVLVFTFVLLLLANPILKLIGTSGASVISRVMGMILSTVAVDAILNGFAVL---
116 UniRef50_A1ANN4 Multiple antibiotic resista... 131 1e-29 1 22.7% 2:195 6:199 -SFFFGIWIKFFFLLTPFFVLSTFLSMTQRYEARERRKLALRVTVAVLVACFTLYFFGNTLFSLFGITLDSFRIGAGALLFLSAVQLVYGDDKAPPG--GEREVISVVPLAIPITVGPGTTGALLVMGAEIQQSWEILVgaLATAVLCIGLLLFCAASIEHLIGKRGIIILSKITGLFVAALAAQIVFTGIRNFM--
117 UniRef50_Q08WP7 Putative uncharacterized pr... 131 1e-29 1 31.4% 37:195 2:168 ------------------------------------RRTALRACLVACGLLLFFAVFGGVIFQVFGVSLGAFRIAGGILLLITALDMLRARPTETRTSRTekEDVALVPLAMPLLAGPGAIASAMVLMAKGGTLLMtvLAAIVLTFVASYFILRASHLVQRALRQSGVAILERVMGLILAAIAVQFMADGAKDLL--
118 UniRef50_D1JAD6 Conserved hypothetical memb... 131 1e-29 1 25.0% 1:196 8:214 LTFSIGAIIAILVISNPISTSAIFIALTERMSRKQKQDTIKKSLTYSAGILILFALTGLLLFRIFGFTIGAFRIAGGVLLFTTAVGMLNPKTSQE-EATDVPDNIALIPLSIPFTAGPGTIVTVVVLMSEVENImlGVFIGIATCLGVTYVMLAKSDLIDGALKEGGRRVVTTLMGLIVMAIAIQFFINGIKDILP-
119 UniRef50_Q2SCP9 Multiple antibiotic transpo... 131 2e-29 1 25.1% 2:196 5:208 -HEYTKILIGLMAIVNPVNAVPIFVAFTSNVSGAERKKIGKSVVIAVGLILLISMLLGEYLLSFFGITINSFRVAGGILILLMAISMLHAKVSatVEEEGHHHSVAIVPLAMPLLAGPGAISTVILYAHRGTdhYALVGVAILILCLTLWLVFSMIPWFSSHLTKTRINIFTRIMGLILAAIAIEFIANGLKGLFP-
120 UniRef50_Q89AL9 UPF0056 membrane protein bb... 130 2e-29 1 26.6% 2:193 9:209 -SIYISFFFSLFALVNPIGMIPIFTSMTNHQSIVERNKTNLIANFSVAIILSISLIFGSFILNLFGISINSFRISGGILVMIIAISMINGNFINNIndKDIARNISIVPLAMPLIAGPGAISSTIVWSTHYSsnIFGCMVTIMLFSCFCWTLFKVSPIIVDILGRTGINIMTRIMGLLLMSLGIEFILAGLKA----
121 UniRef50_A5EYD2 MarC family membrane protei... 130 2e-29 1 44.9% 3:189 2:191 --SLTAAILTLFLIINPLGNVPVFLSILKNLSPKRQRIVLLRELCIAYAIMVVFLFGGSSILHGLNISREAVSISGAIVLFIIALRMIFPLRSGsaDDTEGEEEPLIVPIAIPFVAGPSLLATLIMMVESDPSLTTRWFFAMTISWFISLLIFLCAPFFFKILRKRGLKAVERLMGMILISISVQMMLN--------
122 UniRef50_C7R1Q1 Multiple antibiotic resista... 130 2e-29 1 26.0% 1:196 7:205 IRLLIEVYVTLFVIMDPPGTVPIFLGLTGSMTAKQRAGAARTAIAVAAGVILAFAAFGQQLLTYMHISLPALQASGGLLLLLIAMQLLTGKMEEEADSPSNKnnVALVPLGTPLLAGPGAIVASMLFVQraSADWFALAVGFAAICLTLWVSMRFAGVIHRLLGESGTILVTRIAGLLLAAIAVQLIADAVIAFVR-
123 UniRef50_A8GDQ2 Multiple antibiotic resista... 130 4e-29 1 23.9% 16:195 23:221 ---------------NPLTTVALLLGLSGNMTREERNQQSLMASVYVFFIMTVAFYAGQLVMNTFGISIPGLRIAGGLIVAFIGFRMLFPQQSADEAPEVESknIAFVPLAMPSTAGPGTIAMIISSASSVKENTLGfvAIFLSVALILWACLRSSGAIMRLVGQSGIEAISRLMGFLLVCMGVQFIINGILEII--
124 UniRef50_B8D4C1 Multiple antibiotic resista... 130 4e-29 1 29.7% 1:195 4:197 LIILLSYFTQLIAIMNPFSAIPTFMSLTEGLERRRRLEIVKKAYFAGLILVILFTLVGRYILEAFNISIASLRVGGGIILMTIALDML---GDEVRTKRMHPGDIAVVPIATPLIIGPGTITTILLLTsqETTGMVVVLIAGVIACSVTFLILALSDILTRLLSMSTVRAIGRFMALIISGVAVEMIVQGLYSYY--
125 UniRef50_Q2RRC7 Multiple antibiotic resista... 129 6e-29 1 29.7% 1:195 2:208 IDSLLSQITTLLVLVDPLGLLAIFVGLTAGRPAAYRRQVAIKGTLLATFVLVAFAVAGGKFLHLLGIDISAFRIAGGLMLLVLAHEMIFAKRTIRRNEsgETSDPSVFPLAIPLIAGPGAITAVLLFSRESDGtlMWVIVAILAVTLPTLALLLTAGAVQRMLGETLTHTLDRLLGIILGALAVQFIISGAKEAL--
126 UniRef50_A8HQV8 Putative uncharacterized pr... 129 6e-29 1 25.6% 2:196 6:205 -DLFITQFVTLYALLEPIGHLSLFLALTGEHSKADRLRLAILSPLFAFAVLSFFALAGQTLLNAMNVSILSFQIAGGIILFSFSLSMIFGEAKKPSGVPEEKnsQAIYPLATPTIAGPGAILSVVLLADNNRGSLimTVLAVASMMLLLMGAFLAGDIITRLIGSGGTNLVRRVMGILIAALSVDLVLSALAKWLH-
127 UniRef50_A5GJB9 Uncharacterized conserved m... 128 9e-29 1 26.3% 3:196 2:201 --SLLHTAVGIFTISNPIGNLPIYLSFTDGNRRKDR-AIARSSAVTFLVSLMLATWLGNDLLGFFGISRPAFQVAGGLIVVLIGLSMLRSEPSKVHHDPASIErkGIVPLGIPLLAGPGTLTVVIADPNAAsgGKLGISGVVLLLTVVVYVIFEAGEMLSSKISASALQVLTKIMGLLLTSIAVQMIFTGLRAGFP-
128 UniRef50_C3X219 Predicted protein n=2 Tax=O... 128 9e-29 1 22.6% 3:197 5:204 --FLIKKTLTLLALVDPLMAIPLFICATAGLDTGFKDKYSRQLGITVALSLLIGGLFGLHLLDFMGVSLASIQIGGGAIMFIVSLAMVIAKEETIKYTPRETEepSIVPLGIPLLAGPAALSYVMATSqtQAEDLLSVILPPVVVGAATWLCFRFVGRGGRILTPSAIKVIERLAGFLLTAISVEMMATGFRHVFPG
129 UniRef50_D0XZK3 Multiple antibiotic resista... 128 1e-28 1 26.4% 5:197 8:216 ----LNFIVALFALINPIGNLPVFAAMTAGAKPKARRRIAVYIGVFIIGLLGIFYLSGLALLQVFGISLSAFRIAGGAILFLLGLDMARNDLNGGDEADELAseRILVPFAIPILIGPGAISTVVIYASETRSMGMDAMAaiCAAAAAVVAVLWATPFISRLLGRVGMTVTVRVLGLILCAMAVQFMIMGAADATHG
130 UniRef50_B9NS57 Putative uncharacterized pr... 128 1e-28 1 28.1% 1:196 1:208 MNNLLEHFVTLWVVIDPIGTIPVFIAVTAGIAAGARRKTALLAALVSAGILLFFLIFGQLVIEALDIGLNSFQVAGGIILFLFALTMIFGESKQAVEQRQAEEdpAIFPLAVPSLASPGAMLAIVVLTDNNRYSIaiTALVMLAVIAIAFVLMLLAEPIIRLIGHSGAAIISRVMGMILASVAVNSVLSATIAIIK-
131 UniRef50_A1VE68 Multiple antibiotic resista... 128 1e-28 1 41.1% 1:197 23:221 MQDAFEVALPLFLIMDPVGNAAASLAILREHTPSRQRAIIRRELVFALAIVLLFHFLGDALLGLLDIEQSTLRLSGGIILFIIAMKMVFP-PAQENDPEAVTRDPFIVPIAVPLIAGPSLLAAVMVYARQAQAGmaSVLGGVLMAWGATALIMAFTPDLARILGPRAMRAMERLMGLILILMAVQMLENGIRIFVQS
132 UniRef50_A3DKT0 Multiple antibiotic resista... 128 1e-28 1 27.2% 2:196 3:196 -DLLFAYYIQLLAIMNPFSALPTFLSLTDHLDEIERKDIVRKAFITSIILVILFSLIGNYILLAFGISIASLRIGGGILLLVIALDMLGGMP---RTKQIEYSDIAVVPLATPMVIGPGTITTILLLTSREPgnIFLVLIASILAATTTFIMLRYSTKLVSILRVSVIRAIGRFMSLIIASVAVEMIALGIISFYH-
133 UniRef50_B8ICA0 Multiple antibiotic resista... 128 1e-28 1 21.4% 1:196 8:227 LQSFLLALPALFSIINPLGGALIFAEVTGRRTHEERVLLARRIGIYAAAVMLVSLWLGATLLSFFGISLAALRIAGGLVVAAQAWRLlkTRDREVGVESGGLDEIAFFPLTLPFTTGPGTISVIIALAASRpgFLLGATLAVLVIAASVRIAYASADRVVKRIGHARARVLGRLSAFLLLCIGTQITLTGVSDVLE-
134 UniRef50_B2KBR5 Multiple antibiotic resista... 128 1e-28 1 44.1% 1:195 1:193 MEFIFSAVFTLLMVMDPFGNMPIFITALRKVSPERRRFILIRELCIALLIMLAFVFLGRQFLGMMGIKEYSLSIAGGLMLFIISLKLVFGSSEDPGANPKD-EEPFVVPLAIPLVAGPGSLSTIMILSAQSPSKSIIWM-AVLIASALNLIILLFSFPISNLLGRRGLLALERLTGMLLVLLSVNMVMSGVADFM--
135 UniRef50_A9W5P7 Multiple antibiotic resista... 128 1e-28 1 23.6% 1:195 11:222 LTSFLLALSSLFSIVNPVGSALMFAQITSDRSQAERAELSRRIGFYAALVMLAALWAGAPILNFFGVSLAALRIAGGLFVAAFAWTMLTAPEAREARKHAEVeeVAFFPLTLPFTTGPGTIAVAIALGANRPSEPGELalAALAIAGVIRLAYGSADRVVTLIGSVRARVLGRLSAFLLLCVGTQITVSGVSDVL--
136 UniRef50_B5JIG7 Putative uncharacterized pr... 128 1e-28 1 26.9% 1:193 4:204 LEYTLLAFVTLFVIVEPISIAPIFLAMTAGNDRSARTRTAKIACVTMVTVLLLFAVVGMSLLEFFGISVAAFQTSGGILLLLIALDMLQAKESSRKITQEEseDIAITPLAVPLLAGPGAITTCIVLANQAEAwrMALYGVIIFICGLTFLILKLADKGAAWMNPLFMRVITRLAGLLLAALAVQFIFNGLRD----
137 UniRef50_A6VX13 Multiple antibiotic resista... 127 2e-28 1 46.1% 3:195 6:196 --SILSATLLFLFVIDPFGNIPILLSVMKGVPQKRQYQIVVRDGLIGLVILVCFLFFGAEFLALLHLETESISIAGGVVLFVIALKMIFPSPYTKDAGP--VMEPFIVPISIPMLAGPSTLATLLVMVKSYPNDQQNLLISVGAAWAISVAILAMAPLLNRILREKGLAALERLMGMLLLMMSVQMLVNGVRSLF--
138 UniRef50_D1N0K9 Multiple antibiotic resista... 127 2e-28 1 43.1% 1:195 1:197 MDTFSSMLILFFLVMNPLGNLPVFIAELDRQPPERYRFIVLRECLIALAILLLFVFCGGEILKALRITQASLELAGGIILFMIAIKLVFGSASGSGEKKSAPeePFIVPLAIPLFAGPAAMSTAILVGGRGGfhTLEAAGALAAAWAICTAILLSGRYAGKFLGAKALSALESLMGLLLTTMAVEMIIAGIKYAF--
139 UniRef50_D1N302 Multiple antibiotic resista... 127 2e-28 1 27.4% 1:197 4:203 VNMFIGMVVQFFFLLTPFFVLSLFVSLTSGMELPRQRKLAVRTTLAVMTIVLIIYLLGDRIFGYLGISLDAFRIGAGLVLLLSGIEVVRSSGTPSGTRQCDDddIAVVPLAIPYTVGPGTIGTLLTMGASADSARLRviAGIVIAVLIMGLLLYFSAALERLLKKKGLNILSKLTGLFLAALASQLIFTGIRNIMFG
140 UniRef50_C5CP73 Multiple antibiotic resista... 127 2e-28 1 24.7% 3:196 6:211 --DLIKPLVTLVAIVNPLAIVPFFIHYTQGYSDAQRRHTVRMSAFSAFVVIAVSALIGLQLLAFFGISIASFQVGGGLLLLMSSLSMLNAKPAESKTNVEegASIAVVPLTIPLLTGPATISTVVIYADKTQHLwgLLVGYGVVVALATALAFSLAQPIARVLGKTGINIMTRLMGLILAALAVEVMADGLGKLFP-
141 UniRef50_A3DL90 Multiple antibiotic resista... 127 3e-28 1 26.7% 1:195 5:194 VYQLVSAILMLFVVLDAPGNAPLFYFFTKDMEPWKRIYTIRKSIIVAAFILLLFGLFGDYILLYFDITVNDFRIAGGIILFIYAVLGILGHTTAE---EVSGEEIAVVPLATPLLAGPGSITVVIYL--KYSMGLLLTMLSIAINMIIAWILLENGGKLLQLLGKQGSTVLSKILAILLAAYSVAMIREGIISLI--
142 UniRef50_Q2FRJ2 Multiple antibiotic resista... 127 3e-28 1 31.1% 3:195 7:214 --YLVGAIGTFFAILDPFGNLPFFIAYTNTLSAPVRRKTALVLSAFIFVAMAVFLFSGQMVLSFFHISLPAFQIAGGIILFGVALSMMSGTHTITmeKNESILPTIIVPLGIPLYVGPGSIAAAILFGSNAPTETAFLGGLLVILLIVIFITilSSDYIGKVLGNQGIEILVRLMGLVLAAIAVQLTLDGITGAI--
143 UniRef50_D1R808 Putative uncharacterized pr... 127 3e-28 1 46.9% 3:196 5:196 --SLFSITLVLFLIMDPLGNIGSFREMLKRIDPKKQKIIIMREMLIALFTMLVFNFLGEVIFEYLQVTETTVQISSGIILFLAALKILFPSKDSPRSNLPQ-EEPFIIPLAIPLVAGPSLLATIMLY-AHMETSVPLMLGSIFIAWGLASIILLFSNRLYTVLGNNGLVAFEKLMGMVLILLAIQRFLEGVENFVK-
144 UniRef50_Q4FNW7 MarC family protein n=2 Tax... 126 3e-28 1 27.2% 1:195 2:201 LEIFIQTFFLYFIVIDPLGNTPLFLAVTQNMSSQQRVKTALSATIIASIILLFFAFLGSTLLNYLNISFPAFTIGGGIILLIISMEMLFDKRQQRKEDDIdsENVSVFPLATPIIAGPAAITSVIVSVSDMGSNFTNqmIALASVLLLTFIFFFTASKFSQIINKKVISVISRVIAIILVGLSVQYILDGIKTFL--
145 UniRef50_A4XNM2 Multiple antibiotic resista... 126 3e-28 1 46.6% 3:195 2:193 --DIFSIAVLIFLVTDPFGNIAIYIAALKNVAPRRRLWIAARELLFALGLLLLFLTFGDKFLSSLGLSREATAIAGGIILFVIAMRLIFPSPQGLLGDVPDG-EPMLVPLATPAVAGPSALAVLMTLRNTHTGPLWELYLAVILAWAATAFILLQASFLQRFLGNRGLMAVERLMGMLLIMLSVDMLLDNLQSVF--
146 UniRef50_A9HK24 Multiple antibiotic resista... 126 4e-28 1 22.3% 2:194 22:232 -DTFLLAFPALFSIVNPIGASLIFTQVTAGRARAESLALARTVALYSAVLLIASIWIGSAILAFFGITIDSLRIAGGLVVAVRAWALLQAPEEAAARKEQQatEMAFFPMTMPFTVGPGTISVAIALSAGRPASSGWLvlAAIVVAGTIWLAYAYAERLMALLGVTGARIVSRLAALILLCIGVQILSAGIKGL---
147 UniRef50_D1JAE0 Conserved hypothetical memb... 126 5e-28 1 28.0% 3:195 10:200 --LLAKSFIMLFVVMDPPGNIPIFMALTKGMSGGERKKELNHAVVVATILLLLFAFLGTMILYVLGITPDSFMIAGGILLLLISFDLLRGEHKYGTSG-DSGAGVGAVPLGTPLLAGPGAITAVMVLMQE-ENGVFIALFAIFTAIIATRFLLGQAERIYSIIGKVGSEVLSRVIGILVAAIAIEFIAKGIAGMF--
148 UniRef50_B5EQ08 Multiple antibiotic resista... 126 5e-28 1 23.9% 1:197 20:222 IEIFIQTLVTLLVLMDPIGIVPIFVSLTREQSTDQQKTTAKYISIVVALVLIISTLFGNDILRYFYIGIAEFNVSGGLLLLLMSIQMLTTDNISTTFGQGQASarLVTPLGIPFLAGPGAIGTVIIYGQHAHtsYGLILIDVLIASFAAYIAMHNAHHISRFFGEIGIEIITKVAGLILGAIAVRFICQGLIRLLPG
149 UniRef50_Q6MDE2 Putative uncharacterized pr... 126 5e-28 1 43.2% 4:195 3:192 ---IFNIALVLFFIMDPIGNISSYQTMVKELDRRHQSKIIFREMLIALVAMIFFNYIGEFIFDFLDLSETTVRLSSGIILFLIAIKILFTANDSPRANLPQG-EPFIFPLAIPLIAGPGLMATIMLYAHLEPY-QSIMLASILIAWTLSVIILYFSKKIKSFLGESGLMASERMIGMVLVLIAVQRFLEGILLFW--
150 UniRef50_A8A8R0 Multiple antibiotic resista... 126 5e-28 1 26.5% 1:196 3:193 LNAVINAFISMLIIIDPFTNAPIFYQLTSSFEPKRRKRIIVRSATVSTIILLVFALFGDLIVRPFGMTLEDIKVATGLILLIYAIQALLGKSEAEM---IDPESVAIVPMAIPMLAGPGAISLVLYYRSVLE--PYELALVVVGVMLVSLPILLLGGYLDKLLGKNGTLALNRILAILMAGLGIAMVREGLLTFIR-
151 UniRef50_C1DWJ6 Putative membrane protein n... 126 5e-28 1 27.2% 1:195 4:206 LYLILKYTISIFAIVDPFGAIPLIISVLKNFSDKEREFIIKKASIYGCFILIFFLFLGNFFVGILGVSIADFQIAGGIILLLISINIIFGQPLKEKISPEEieNIALIPVATPILAGPGAMVTAMTVASSQESLLNLLIVAISIVilISYFILKASKYIQKLLGEIFLDIVSRMMGIVIMALAVQFIVKGIKQNF--
152 UniRef50_C5BLR4 MarC family integral membra... 125 6e-28 1 28.8% 1:191 1:201 MEYFIVAFMTFFATIGPLDVAAVFAALTARYKPREARKMAVKGILISISILLLFALSGEWLLSQLGISLAALRAGGGILLLLIGIDMVFARTSgeEEEAITREDISVFPLATPLIAGPGSMGASILLMANAEGHPWQqlLALAAILLLTLVMLLAAAQIQRILGVTGMHVITRVFGVLLTALAVQFIFDGV------
153 UniRef50_D1R807 Putative uncharacterized pr... 125 7e-28 1 39.7% 2:195 4:195 -QSIFSIALTLFLVTNPVGNAPAIIALIKDFDFSRQKAIMLREATFSLLLALFFQYFGEVFLNTLHIDRYTVSLCGGTLLFLISLSMIFPLHHEETVKAT-KHEPFFVPIATPILSGPGLLAMIMLLSAQVSSNFA-MSLAILLAWVGVFFVLLIAPYLNRVLGKRGLLALEQLMGLVLSIISTDMLVKGVEQFI--
154 UniRef50_B0UBD2 Multiple antibiotic resista... 125 7e-28 1 21.0% 1:195 11:250 LQSFLLALPALFSIVNPLGAALIFAEVTGGRSHGERALLARRIGLYAAAVMLISLWMGAALLSFFGITLAALRIAGGLVVAAQAWRLLAAPEEREARKAAQAeeIAFFPLTLPFTTGPGTISVAIALGASRpgFLLGASLAALVIALSVHLAYASADRVVARIGPARARVLGRLSAFLLLCVGTQITLTGVVDVL--
155 UniRef50_A5G1Y0 Multiple antibiotic resista... 125 8e-28 1 24.9% 1:197 3:215 LAFAARFLGAFFAIMNPFVTLPIFLSMTADRTVAEQRSIALQIGTYSTVMCLVIAVAGNAIIGFFGISIDAFRVAGGLVLLGIAFSMLNGHPITAHERGDHEKsiAFYPLTFPLVVGPGTIATLIIYAGQARGVPEYVAFGLilLLAVLIVVLYFAASIGRLLSARMRVVMTRLMGMILAAIAVGMVTAGLKILLPG
156 UniRef50_A4BBV6 Putative uncharacterized pr... 125 9e-28 1 26.3% 2:195 6:206 -TFFFNALTSYFVVIDPIGCALIFYSLTLGQSTRQKAKTILKSMAIALGIILSFAIAGERLLTALGISMDALRVAGGILLFNTAFRMITKVPEDQSLHHESPHdiTVYPLAIPLMAGPGTLTLTVLLMANGEQTvvMVIVAAVIVLLVTVLLSVLSGKLRKVLGQTGDEIIQRLLGVLLAALAIQFVANGVNGLF--
157 UniRef50_C4XI48 MarC family integral membra... 125 1e-27 1 20.6% 3:196 4:203 --TFQHYLLGLFAVANNIPALPLFMNLCRGAQTPVQHRLCGVATASSLATMAISLFIGAAVLDFFGISIAAFRIAGGLLLVSSGLSMLKSSCDEADGLPPVSVsmAVVPIAIPLTTGAGTISTIVLFAESAHTMAGLLRiaICVMSVVNYLAFYYSPAIVRFLGRTGMDIFTKIFGLITLALGIQFIITGLTAAFP-
158 UniRef50_A8ZZM6 Multiple antibiotic resista... 125 1e-27 1 26.8% 2:195 3:196 -HLFLSLWIKLFFVFTPFFGLSMFLSLTEGYDEPRRRRVALTVSLAVAVLCLLLFFGGRQIFSLFGITLDAFRIGAGALLFLSGVGLVQGKP--VNAGVASGSELAVVPLAMPIIVGPATIGILMVMGAELEGVREKMAgaLLAAVACITVVLLMGSFIYRRLGAMGIGILSRLTGLVLAALSAQMIMTGIQAFL--
159 UniRef50_A6SZ91 Multiple antibiotic resista... 124 1e-27 1 21.9% 9:195 14:218 --------ITMLPIINPFGNAPVFASLLGNVSRDVEKKLARQVALNCFFLLLGAMFIGSHVLMFFGISIPIVRISGGLLVAFTAWRLLNDNGQdeAWSDEEFKVRSFYPISFPLTVGPGAIAASITLGASTPARLLDQVISLGSAAvvIWLCYNSANKMVKMLGRLGTMVMLRLSAFILLCIGVEIFWTGVVGLL--
160 UniRef50_Q3SH12 Multiple antibiotic resista... 124 1e-27 1 27.2% 14:197 20:212 -------------IVDPVGVIPIFLMATHGFTLTQSRAAARIAALTVLGVLTIFAFAGETLLTFFGIRLAAFSVAGGLLLLLLALSMVEAHVSPQRqeAEEKDSVGVVPLGVPLLAGPGAITHVIVAAGALEGHTllLLLPVGLVALSVWLAFRAAPVIAKRLGKTGIHVVTRLMGLIIAAISIEMIARGLGELFPG
161 UniRef50_Q01Z86 Multiple antibiotic resista... 123 2e-27 1 21.0% 2:196 12:221 -KTTLLIVGALFPIVNPIGNTPIFLSLTHGLSSQGRTVLARMIAINGLILILASIFIGTHILAFFGISLPVVQVGGGMVVIATGWTLLRQPNDDGSGDSGARDeqAFYPLTLPLTVGPGSISVAITVGANRPEgiGGMLLGSALIAVSIYLSYRFAERLAQTLGDSAMNVMIRLSSFILLCIGVQILWNGLSALLR-
162 UniRef50_B1ZVN7 Multiple antibiotic resista... 123 2e-27 1 27.9% 3:192 7:192 --QFLQAFIPLFVAIDPIGLAAIFLALGTGVPLEQRRRIARQAAWTGGGVALLFLLLGQTIFGALGITASDFQIAGGLILFIIAARDIM--HSAAEAPAKLADDFGVVPLGMPLIAGPASITTLILLAQTVGVWIS--LAALAVNLVLIVLAFAYSDKLGRLIGATGMRAISKIISLLLAAIAVNMIRQGVA-----
163 UniRef50_B1YA24 Multiple antibiotic resista... 123 3e-27 1 25.4% 1:193 8:196 LMELLTAVVALYVIVDPLGNIPLFAALTAGLSEAQRSRVLLLSVLVASAVLVLFAVFGVEIFGYFGVELGDFMIASGLIL--ISFSLHQLIRPYEQRPATDGLEVAVVPLAVPYLAGPASISYVLLMSKHMG--VAPTLLAVAAVSLLTFATLRASGFIMRALGVLGIRVVEKIMLILSVAIGVSLVRRGLEA----
164 UniRef50_D1B0T6 Multiple antibiotic resista... 123 3e-27 1 27.2% 2:196 6:209 -NLLLQHTITMMAIVDPLGVSAIMLSLLPQSTTKEHikIARKATLTIIVAFFVVLISGNFLLNLFSIEIDSLKVMGGIILLFTAIKMVQgqTEEEREEAIKNDEFSVIPLGVPITFGPGIFATIIILRGHSEgsIAALIMAYLIVALSVYLAFKNSIYIRKYLGITGQKIVSRLMGLIVGAIAVQFIVGGVSVLVK-
165 UniRef50_B5HXX6 Integral membrane protein n... 123 3e-27 1 25.8% 4:197 7:200 ---FGSLFLTLFVIMDPPGITPIFLALTAGRPGKVQKRMAFQAVCVAGGVIAVFGVLGHQILDYLHVSVPALMIAGGLLLLLIALDLLTGKTDEPKQTKD--VNVALVPLGMPLLAGPGAIVSVILAVQKAHSVATQVSvaILAIHVVLWLVMRYSLLIIRVIKDGGVVLVTRLAGMMLSAIAVQQIINGITQVIQG
166 UniRef50_B0U0F2 Multiple antibiotic resista... 123 4e-27 1 24.1% 1:195 7:207 IAVILKFIISLFAIINPFSLAGIYLDTVKQSDQKEKNTIVFTMILAFLAILSLMVWFGNNILSIFGINQDAFRAGGGVIVLFFGLRilAQPVSDTTVKIVSARDLAVVPLAIPLLAGPGTIATVITDSHEYFATIESKVIalLFVAIVLWLFFRYLPKISAFLGEHTIDVISKIMGLMLVAISVEMIFDGIKGFF--
167 UniRef50_A3YU86 Putative uncharacterized pr... 123 4e-27 1 25.6% 2:196 9:215 -HFMVQFVTSMVALLNPLGDFALFLALTQGRSRAEQKSIGNQAAVAIGVIMLTSLWLGRAILGGIGISIGAFSIAGGIVLFGIGLGMLNSKSGDSSKTESNQDNiaVVPLAIPISAGPGVITALLVASHSNEAGIPGLlvASVVMAGMMAVVFWYAPALGRLMGPSGMQITTQIMGLIVTAIASQMVLNGLKSAAP-
168 UniRef50_Q31LF6 Multiple antibiotic resista... 122 6e-27 1 31.8% 3:194 5:210 --LVLNFAVALFAVTNPLGNLPIFISYVGKEKPSVQRLLALFLVLTVFISQLVFLLSGTAILRFFGISLAAFRIAGGIILLLIGINMIQGDRTKANQkaETVYQSFFIPLGIPIFVGPASISTAVLYGNLANNLalGLIGAVIAICIVSWLTLSVASWFERILGDLGLEITSRLLGLMLAAIGVQFILNGLGEA---
169 UniRef50_A2A0C4 Membrane protein, putative ... 122 6e-27 1 28.4% 1:197 1:202 MSELINSFLFLVAVLDPIGSVPVYLEATKDFDKKHKKKIAVRASFIAFMILLAFIVIGQFFLEGMSITLDAFRISGGLILFLFSLTMIFGESKPESEKqtDYKHVTIFPIAIPSIASPGAIMSVVILTDNHIYTIEQQIVTTLLVALVVflILLAAVAVQKRIGDYGIIIISKVMGLILASYAVQNILSGLKNFFMS
170 UniRef50_A8UZ22 Multiple antibiotic resista... 122 8e-27 1 24.6% 1:195 7:210 LRTLLQFTIGLITILNPIAAAAIMVSltPPVSKRELVSISKKTTLTILTASLLSTFLGDLIFKLFDINIHSIKVIGGIILLLFSINMIKGktPEEHEEAKEKDDISIIPLGIPILFGPGTFTTLVIFKTSTHNWifILITAIFISSVVVFLVFKNAVLLDKFLGITGVKITTRIMGLIVGAIASQFIVSGVKSLW--
171 UniRef50_B2UQV9 Multiple antibiotic resista... 122 8e-27 1 42.3% 1:194 1:198 MQDFLSTVILLFIVIDPVGLAPMIQGMLKKYSPAQQKAILTRELVFALSLLLLFFFSGKFLLNLLGLEPSTLSISGGILLFLVALGMVFPAKdsSSGRADGKDEPFIVPIAMPLMAGPSSLSIIMLHASQTPDSISQmaGAIVTAWFLSGMVLFIAQKFLRLLGEKGTIALERMMGMVLIMISVQMFMNGLAGY---
172 UniRef50_A1TTZ1 Multiple antibiotic resista... 122 8e-27 1 20.2% 2:194 11:219 -KSFLFVIAALLPIVNPAATAPIFLGLTEGASPTTRALLARRIARNMFWLLLGAMLVGSYVLEFFGISLPIVRVGGGMIVAATAWRLLTATQATVDSRTELAESfaFYPLTFPVSCGPGSIAAAITVGVSLADARLSMSLalLSVAVLLYFAFRYAQQLLKPLGEAGSVIFLRLSAFILLCLGVQIVWDGVYEL---
173 UniRef50_Q4LEJ1 Integral membrane protein o... 122 1e-26 1 23.7% 2:195 7:194 -DELIRASVSLFIVMDPIGLVPLIASLTSKLSIEQSRRVVRSTIYTASALLLAFAIAGHYILEAFGISLSSFRIAGGLLLLLL----SFELLLKGWELKGNEISIGAVPLAFPLLVGPGAITTILISLDRYG--ILVTMLSVAIVLALTMLTFSFMNTLNRLLGNLGSLIVSRVMAILIAGIAIEFILSGVEEFI--
174 UniRef50_A1S0Q7 Multiple antibiotic resista... 121 1e-26 1 25.8% 5:194 13:198 ----LFVAVQLYAVLNPVSVIPTFVNLTEGLDSREKVHAVRKASMIVFSLMVVFSLIGDPLLRLLNVSIASLRLGGGVLLMVIAVDMLSGMSRTK--GLESGDEALVVPIATPLLVGPGTITTLIVLSASEG--LPVTLLGALLATLLVYATLAFGESLLELLGRNFVRSLGRFMAIIIAGISAEMIHRALLEW---
175 UniRef50_B5YIN6 Putative uncharacterized pr... 121 1e-26 1 26.7% 1:195 4:193 LNTFLLTFIPLFVAIDAPGILPLYISLVEGVPDKERKHIARQSVITAFLVGTLFLFLGNFIFSLLGIKLEDFMIAGGILLLILSISDIL---RVKEKELTISDTLGVVPIGTPLLAGPATLTTLIILAGNYGYPI--VIFSLSLNLLIAWVMLEKAEFVIKVMGIHGIKAFAKVMALLLSAIAVSLIKKGLTKIL--
176 UniRef50_A4X2W3 Multiple antibiotic resista... 121 1e-26 1 25.6% 1:195 3:197 IKLFGEVFVTLLVIVDPPGMMPIFLALTGPLSARDRHRAAWQAVALALGVIAIFAVAGSTLLDYLHVDLPALQAAGGLLLVLVALELLTGKADDPSQQATS--NIALVPLGTPLLAGPGAIVATMLFMQQADgdITAIAGAIIAVLLAVWVVLRFSGGIVKILRPGGIEVLTRIAGLLLAAIAVQLIADAVAAFV--
177 UniRef50_B6IU07 MarC integral membrane fami... 121 2e-26 1 30.2% 2:193 3:207 -DLILATAVAFLVTIDPIGLGPVFAGLTAGMEHSVRRRMAVKGVLIGAGLLFVFALVGEGLLKALGIGVGAFRIAGGILLLLLAIEMVFARESGIRATPDEraDISVFPLGIPLIAGPGAMTSVVLLMGRASGDlaVVLGVLAAVLALTLVVLLFAAEVSRFMGVTGINVVNRVLGILLAALACQFVIDGLIE----
178 UniRef50_C2BT16 MarC family multiple antibi... 120 2e-26 1 26.0% 1:196 13:210 LGLFISTFTTLFVIIDPFGNLPVFMSLTKDLPKKQRQTVALQANLLAIVILFVFGFFGFQLFGLLGISPAALQISGGLLLLIVALQLLTG-AEGTVGEEGGSLNIAAVPLGTPLLAGPGSIVALMVAMGNAGHHPLSVIAvaFAVMFASWLAMHFATPIIHFLGNSGVAVMTRLAGMLLAAIAVELMISGVISVVQ-
179 UniRef50_A6FM96 Multiple antibiotic resista... 120 2e-26 1 26.0% 1:192 5:202 LAHIMEEFAMLFAVVDPIGTIPVFLAIVISLPEEKRSSVAFKAVLIAGSLLLFFIAFGQMFLEAIGVSLSSFQLAGSLVLLLFGLNMIFGEARQDSeaEKSDVELAVYPLAIPSIASPGALLAVVLLTDNRTTPILEQVItvLVILMMTLACLLLATRVHKIIGNAGSSIISRVMGLIISALAVETGLDALS-----
180 UniRef50_A5FPP7 Multiple antibiotic resista... 120 2e-26 1 30.4% 2:192 6:191 -NNILLTFVPLFIVVDAVGNLPFVISITDQSTAEERKKVVNLAVITASLLGLLFLFMGKLVLDLMGISVGAFAIAGGLILLLFAIRYM---TSGHMVEVIKEEMVAVVPIGTPLTMGPATITTLILLVNQFP--LYIVLISFALNMLATWLIFKSSQWFVHYMGRGGLKAMSRIFSLFLAAIAISMIIKGLR-----
181 UniRef50_A7BE02 Putative uncharacterized pr... 120 3e-26 1 19.7% 7:194 11:203 ------AILALAPITNPIGGLAAFAGLTAGNAAAAVRSQAWKTGIYVFAILTVFAVSGSLIMRFFGFDLPSLQIAGGLVVSHSGFSMLENKRRATHEETQHAtdVSFSPMALPLIAGPGSIGVVIALAARNTAIGFHvvLGIAVTAAVIALLLRYGTPWIDKLGATGVGAIVRIMGFLILVIGVELIIHGVRAL---
182 UniRef50_B2J6W5 Multiple antibiotic resista... 120 4e-26 1 28.2% 1:195 3:195 ISILVQTFIAVFVLADAVGNIPIVLVLTKGMMPDQRNKVIDKAIIVAIAVLLLFAFAGQVILNYLEISIGSLRVAGGVLLLLIALQMLRGELDQPI--IEEGRDVAITPLALPLLAGPGTLTTVMLLMSKSQSPHIAVAVGILGAMFITWLILRLANLIDQWIGAEGGVIVTQLLGFLLAALAVEIGSTGIRELF--
183 UniRef50_B2TBL8 Multiple antibiotic resista... 119 5e-26 1 21.0% 1:195 6:214 ISDILFGFTGLISIINPIGIAFVFLDRTASLTTEERTALARKIAINVMCVLLVAFFIGTPILHFFGISMQALRIGGGLAVAVGGWQMLNAPDTQPAEKpdNAMSKAFFPFTIPLTTGPGSIATAVALTANRTHKLSEFVISSIavAVTVYLVYSRAVVFAKYLGVEGTKVAMRVSSFLLLCIGVQIMLTGFSEFL--
184 UniRef50_B9L924 Putative membrane protein n... 119 6e-26 1 42.8% 3:196 2:190 --DILHIAVTLFLIMDPFGNFPVILSLLKDYNDKEKLQIIIRELIFAFVVIFIFIFFGKNIMNFLGLREESISIAGGIILFLIALKMIFPSSDPMFGKE---NELYLVPIAIPMIAGPSLLATLILFSSQYG--ISEVLGASLISWTLSALIIIISLKFSKIIPNRVFSAVEKLMGMLLISLSVQMLLDGIAKYLH-
185 UniRef50_Q6L037 Multiple antibiotic resista... 118 8e-26 1 29.6% 9:194 1:184 --------MPLLVVIDPFGSLAIFVSMTASYNKDTKLSISRDAVLYGGMILIIFAALGEIIIQFFGISIEALEIAGGIILLLMGIEMVREGAKPES--SSGSKNLGIVPFATPLLAGPGAISLVIILMKGSLTTKIFTIVSILIVLALVYIFFIFSSKILEILGEKIMTAITRIFGLLLAGFAIQYFLDALISL---
186 UniRef50_Q3A045 Multiple antibiotic transpo... 117 2e-25 1 21.2% 14:197 20:202 -------------VINPLGNIPVYRDLTSGMDFSKRRAMIQLGVGTAAAMIIGFALLGDWSlnLFEVTLDEFRIAGGILLFIVAVRGVMTGSLSYNLLSDDFRTRAIFPLAFPIIVGPGTLAVTIILAQNRP--PLHMLAVSSVSCIIVYLIASSAHSLMRVIGGYAAMIIPRLLYIFLAAKAVALIMHGLTGYVQG
187 UniRef50_C6X1I7 Multiple antibiotic resista... 117 2e-25 1 25.4% 1:197 7:194 LKETLTATMVLFAVIDIVGSIPIIVSLKKRFGHIE----AGKATLAAMFLMIAFLFIGNKILKFIGVDVNSFAIAGAIVIFIIALEMILGI---EIHKNQEAKSASIVPIAFPLIAGAGTLTTTLSLKAEYHD--INIICGIILNTLFVYLVLKSANWIERKLGEGTLQVLQKVFGIVLLAISIKLFTANFAQLFSS
188 UniRef50_C6QAI6 Multiple antibiotic resista... 117 2e-25 1 26.9% 1:193 2:204 LETALKSLTTFFATIGPVEAAVLFATLTPKMPRAERQAIAIRATLIASAILAFFTVLGGPILAQLGVSVAALQTAGGIILLMIAIDMIFARppPEGAEAQTREDVAVFPLATPLLAGPGAMSAGILLTANapFGLAIVVASLACVMIATLALLLLAQELNRVMGITAQRVLIRVFGILLAALAVQALFNGIKD----
189 UniRef50_Q9Y8Y7 Small neutral amino acid tr... 117 3e-25 1 27.4% 1:197 4:196 LYTVVSSIILLFIVLDPVGVSPYVASIVARRPEGERERIVRTALASAGAILVAFTLIGVAVLDILGVSMDEFKVAAGLLLLIYATADLFEIKIGYSE--PSGDEVAIFPLATPLLAGPGSIATVMYIMGS--SGIAVALIAILVNLVLAYPILHASLKLVRLLGRHGSLLVAKFTAFLMVGFAVSIIFDGLRGIVPG
190 UniRef50_C3WBK3 Integral membrane protein n... 117 3e-25 1 21.5% 1:195 8:206 VDAIFINALTLIAVLNPFGNVPLFIGMTEGMEKEIRNKLFKMIAITGFFITWIFSLFGEFLmnFYKINMNELKMAGGLILILMAIKNlrKRTSEKQLSPDEQIKQAVIPMAFPMLVGPGSLTTALI--GRSENGLTSNSFSILVAFIIIYLVLMVGNYLERIFGKLVLYILSKVMQIFIMSIGFRIFFDGLSHMI--
191 UniRef50_B9KCI9 Integral membrane protein, ... 117 3e-25 1 22.3% 1:197 9:210 IYIILLASVAIIAVLNPFGNLPQFIAMTEGLDADTRKKLFRNIIYTAFCIVLVFLLSGPFIMKyfKIDINDLRVAGGLILIIMSTKNLLFTPSSSQFQHYQGLShsIVPMAFPMLVGPGTLSTVVVISEDQ--NLAIAIASVLLTFAFIFALFHFSATIEKVIGKLVLYVFSRIALVFIMAMGVKMIAIGVQTYIQS
192 UniRef50_A1U7B4 Multiple antibiotic resista... 116 4e-25 1 20.9% 2:197 7:206 -STYLSSTIRFLFLLAPFFVVTMFLALTRGLSMAEKTSIIRRACVSAFILGVILFFAGPLLFNAIGITLNSFRIGAGSLLFLTAISLVNSGTRNHATgeEDRDDIAVVPLAIPVMIGPATIGAIMVYGAeaVPEVAGGLLGLVSGLMILAGLLRLSGYLEKALGKTGLNIMSKISGLILSAMAAEIVLTGIAGFIAS
193 UniRef50_Q3JBV2 Multiple antibiotic resista... 116 4e-25 1 26.0% 2:197 12:257 -ELLGNFFAALVGILNPVGKIAVWSELAGDLPPPVRFRLALWNCLIAAGLLLLFLWQGQSILSFFGIQLPAFKVGGGALLFITAVSLFEGKVKENFHLPQEGKshTIVPMAVPLLAGPGTLTIAILFgaEGRGEFLQLSGVLLLSLFFVLGLLSVGPWLERRVGKPLLSALMRIFALLLAGIAAQLILEGLEPVISG
194 UniRef50_Q6MDE1 Putative uncharacterized pr... 116 4e-25 1 33.7% 3:195 2:192 --SVIQLAMIFFIVTNPIGNCPTIITLIKDYSIKQQQKILFRESIFSMILAILFLFLGEIFLTSFQIQNYALTISGGILLFIVALKMIFSDRLKTKTDTPKQA-PFIVPIATPLLSGAGLLTMIMLYSKEEANDL-KMLCAILLAWVGITTVLVTAPYLQIFLGKRGLAALEQLTGMLLAMIAIQMIVQGSGLFL--
195 UniRef50_Q2LRX6 MarC family integral membra... 116 5e-25 1 26.7% 1:195 1:192 MKSFWLCFVPLFVAVDAVGILPLFMSLTEGLETRKLRRIISQSVITAIAVALVFLVLGKALMDLLGITIADFMVAGGILLFVISLNDVLATEKAQQHTV-DPDSLGAVPLGVPLISGPAVLTTTLLLSNSYGFVP--TATALILNILLAGGVFFSSRIIYRFLGKTGAKTISKITSLLLAAIAVMIIRRGLFIIL--
196 UniRef50_A1SUW5 Multiple antibiotic resista... 115 1e-24 1 25.1% 1:195 2:197 LETFFTLYLKMFFMMTPFFVLSIFLSLSKKLSNPAKKVVILRSSIAVAVAGLIFLLFGKYIFSLFGITLDAFKIGAGTVLFLSALEMIKGGEVPENTMKK-GSDFAIVPLAIPSAIGPGLIGVLMVIGAEMSGVLGivILSLLAAVISLAGVLLLSNKLQDLIGEQGLEIIPKITGLFVSAIGAQIIFSGIQGFL--
197 UniRef50_A1RZF3 Multiple antibiotic resista... 114 1e-24 1 23.9% 1:197 22:213 LKELWDTFLMLFIVVDSIGNIPIFYSLTSGMGREERIKIFEKSVAVASALLVFFAVFGYPFFQYYGVSFTDFKIAGGLLLLIIALQGVFGRVEAEALRS---EDLAVVPMATPLLAGPGAIYMVMYLNSVYG--LLPTLVSIALNTLASYLILTKSNVLLEKAGKNTILVLSRIFSLLLAVLAVSLIRSGIYEALRG
198 UniRef50_A8YHS2 Genome sequencing data, con... 114 2e-24 1 26.2% 2:173 4:192 -SFLRNFAITLFALLNPLGMLPIFISYTARERKEVQRLVALFVSLTVLCLLLIFMFIGTAMLKFFGVTLDSFRLAGGVLLLIIGINIVNGSGAGTKeeAKSVYRQIVIPMAMPLLVGPGVIANVILYASEAESKLgeLILMTILVSFLVFLILAAGKWLQRLLGDIGLSITQR------------------------
199 UniRef50_D0MK78 Multiple antibiotic resista... 113 2e-24 1 23.4% 1:197 1:197 MNAYLETFLPLFVAINLPGILPFFIALTEGLSAADRRRLLVRAVATAFVVAVLILFAGQLIFETLGITLNDLRVGGGLILLVLSidLVFAdrRRDPRDGADAADVGVVPLGIPLIIGPAAITTILV--AQQTYGYLPTLVSLVANLLLVTAAFAAGPWVIRKLGPVAVRAIAKVASLFLAAIAVAMIRAGVAGMLAG
200 UniRef50_Q5UEW8 Membrane protein, putative ... 113 3e-24 1 25.8% 1:194 2:204 VTELVSLALIYFAVIDPIGTIPIFLSITERFDYKQKQRVALRGCAIAFFVLVFFGFFGDLILSHLKISSATFNIAGGAILFLISMEMVNGRRQARKSQAVEKnrISSSPLGVPLLAGPGAITSIMVFGDFTSLDKLVilSSIFIALAASALLLYLAAWGSKFINLTISTVMSRLVGILLAAIAIQIILNGLNKL---
201 UniRef50_A5ETX6 Putative multiple antibioti... 113 3e-24 1 25.6% 1:195 5:194 LEFVITTFVTFFVVIDPLGILPIFMALTGKKSVAIRQQIAVRAVLLAGPILIVFAFAGDTVFRFLGISLPAFRIAG-----VPADYGLQPRPKKTRQSKARTWRFFHLQYR---SAGPGAMTSVILIMGKAGSDFLIQLIAmlSVLLLCLLVFLFASRLMAVLGLTGVNVIGRVFGIVLAGLAIQYMLDGFAAYI--
202 UniRef50_A1SV44 Multiple antibiotic resista... 113 4e-24 1 28.5% 1:193 2:204 IETAGLALATFFATIGPLDVAAVFAALTANQTDQQKRTVAIRGTLIGTAILVAFALVGELLLSSLGISLAALRAAGGILLLLIGIDMVFARSSGGTSTTDDEedISVFPLATPLIAGPGAMGSAILLMANQHGDLtiIIFSLLAILFLTFISLLLASKLQNLLGITGMHVITRVMGVLLTALAVQFIFDGIKQ----
203 UniRef50_O84860 UPF0056 membrane protein CT... 113 4e-24 1 28.2% 1:195 2:196 LHSLFRLTLLFYALFNALGSLPVFIALLKNFSFKKQQHIILRESIFALLLLLLFVTFGRGFFRLLGIILPAFQFTGSLLLGSIAIDMMKALPPQTETLERDKDEPIFFPLAFPVITGPAMITSTLGHMEEGIFPKKIVLGAIVLAWLFSLITLLLSSSINRLFGQMGLLALERLFGISLALMAGNLMLKALSTAF--
204 UniRef50_A7I5R8 Multiple antibiotic resista... 112 5e-24 1 27.7% 1:195 11:201 ISGIIYAFAALFIILDPILSVPIFAGMTKGQSAREIHKQAFIAVAVAGILMYIFLVFNTAIFSVLGLTLSTFQIAGGILLFLLGMEMALGIDLCKSKEQVPTA--AGVVIGTPLLCGPGAITTVMLLSNDYG--ILIPFIAISLSLAATWVILYYSAAIQNILGTVITDIMGRVLGMLVAGIAVKIIFSGIIGTL--
205 UniRef50_Q607N5 MarC family integral membra... 112 8e-24 1 37.8% 3:195 2:193 --TLAQVAVLLFLITDPFGNLPLLLTVLQRLGHAAYLRAVLRETAIAFVVLVVFAWKGDLLLGYLNVTQPSLNIAGGVILTIISLKMIFGGAQETFDDRY-ANDPLVVPIAIPAIAGPAALTTVMLLSKQQGIPFPTLFTALTLVFLANLTTFLLGRLLGEWLGPRGLTALERLMGLLLNLVAVDMTMAGIKRFF--
206 UniRef50_Q31NH4 Multiple antibiotic resista... 112 1e-23 1 23.4% 7:194 9:213 ------FATTLFAMLNPLGMLPVFISYTESERRQVQRWAALFISLTVFALLILFLLTGSTLLRFFGISLSSFRIAGGILLLLLGiaIVKHEQESSLRAAESVYKKIVIPLAVPLLVGPGAIANVILHGtqQYGLLAEFALIIALISLLTFIIFQSGRWFQKVIGDVGLSILTRILGLLVAAIGIQFLVAGVADV---
207 UniRef50_C2M291 Putative membrane protein n... 111 1e-23 1 27.0% 1:196 3:189 LEHIAQISFKLFWIIDIIGGLPIFISLMNRFGKIQTEK----AALVSACLMIIFLFAGEAMLRFLDIPLKVFAVAGAFILFIIAVEMILG---VSFHKMEEANSISIVPIAFPLLAGPGVLTMILSLHSSYSS--VDIVISILINVAIAYVVIKHCRRINDWMGQTGIVIANKIAGVILLALSIKMFADNWKTIFE-
208 UniRef50_A3ZTD8 Putative uncharacterized pr... 110 3e-23 1 29.9% 12:195 14:201 -----------IATIDPIGTLSIFVGVTGKSPKEDRPRIALKATLIGGAVLLAFLVLGQFILGALDIRLESFQLAGGLILFLLGLQMVFggPAVEAPKAEAGHDVAVFPLALPSIASPGSILAVVILTDNHRFTMLEqaVVLVVVLGLTYVLMLAANPIHRLIGDTGGMIIVKVMGLLLCALATENCVEAVQQLW--
209 UniRef50_B7VQK4 Multiple antibiotic resista... 110 4e-23 1 23.7% 2:195 12:213 -TYMTLTVLGLLPIMNPPAAATVLLGLSKGRDKSYIVSQAKTTGVYLFIALCITFFIGASVLELFSISIPSLRLGGGIIIVAIGFNMLFPRPDNGAAPSGQ-DSIALVPLTIPSLCGPGSMAMIISLAAqmTSVYGGVVAGLALVALIATFTLTMAYPLLKALGQNGINAFTRIMGFLLICMGVQFFTLGIQEIV--
210 UniRef50_A5FMK4 Multiple antibiotic resista... 108 9e-23 1 25.8% 2:195 7:191 -KEIITVSMVLFAVIDIVGSIPIIVNLRAKVGHIE----SEKASIVAGAIMIVFLFVGEGLLNLIGIDVHSFAVAGSFVLFFLALEMILGIRIYRDEEPGSA---SIVPLAFPLIAGAGTMTTLLSLRSQFHT--INIITAIVLNIILVYIVLKSSKKIENLLGENGLGVVRKTFGVILLAIAVKLFAANVKGLF--
211 UniRef50_C2M9S3 Multiple antibiotic resista... 108 1e-22 1 22.4% 1:196 17:205 LPSFFATFMILFVSIDIIGAIPIALSLKEKGKVFHPSKVA----IISAIMFMAFLFIGEPLLSFFGVDVSSFAVAGSIVLFVLAVEMIFGIQVFQDDDPSGNAD--IVPLVFPLFAGAASFTAILTMRSS-GTANSTLFVAIILNVVCIYLMLRTVSLLERWLGKGGIYILRKFFGVVLLAISVKFFMQNLMIILE-
212 UniRef50_B7K783 Multiple antibiotic resista... 107 2e-22 1 20.2% 5:192 93:286 ----FNLFIIFFVTLGPIKIIPTFVRLTQKADKNFRCQLAFISATISTIVIVFVAIIGQNILKVWQIRLPALMITGGILLFLVALKIVMSqsPKAESPENPSLDLAINPLVFPTILPPFGIatFMVMSPQLGISSVITLALLLLVMGLNLICMLAAHPILSFIKPVTLLILGFILGVMQLALGIEFILSGLE-----
213 UniRef50_C7LYJ4 Multiple antibiotic resista... 107 2e-22 1 31.1% 2:194 4:197 -KFFVEALVTLLVIIDPIGNIPTFLVVTRGRDQRARRRLATEAVLVAAAVLAVFALAGSQILDYLGISIPALEVSGGLLLLIVALELLTGRG-GSIGTTEEGISVAVVPLATPLIAGPGAIAAVLVLAKRAATAPLSVALAGALvmVILWVVLHYASALVRILKESGIALLSRVFGLLLAAIAVQLAAEGIRGF---
214 UniRef50_UPI0001699175 multiple antibiotic resista... 105 6e-22 1 43.6% 3:167 8:171 --EILSIAITLFLIMDPFGNIPVFLSILARVTEERRRVVLARELLLALVVILLFVFFGGTVMSLFGLSRAAVTIASGAILFLIALRLVFPEKEAAADDEFE-DEPLLVPLAVPLIAGPSLLAVLLVFTATEPDARGTLLIAALLAWLATSTILLASTFLYRVFSPCG------------------------------
215 UniRef50_D0SM32 MarC family integral membra... 105 7e-22 1 23.2% 4:197 5:203 ---YIHAFALFFSLLNPFLMSVYMIGMIRNTDAKVFSKALIQGCLIAFIVFILFAWGGESIfrYLNVRFESFQIFGGLIFLVIGYRYVFQGAETIGEMRGAPEHLAGT-IAMPFMIGPGTISAAVVTGISVPFSGAVAVIAITLMLTCSILimKFAHDHLRYKHAKYidIVGRLSALLIGTIAVDMIVNGIMGLIES
216 UniRef50_A6Q130 Multiple antibiotic transpo... 105 8e-22 1 30.6% 1:196 6:213 ISILLHDIIALITIINPIAAASIMISMISPPTASAIADVARKATLTVFAASFVTLFGGEVVFQFFGINIYSIKIIGGIILMLIAINMAYGHGAKNRHSpqEKEDIAIVPLGIPILFGPGVIATIVVLSHNNSssYILLSIAILIASLATYLTLRYASIINKALGVTGIKILTRIMGLIVGAIAAQFLISGIKGLWE-
217 UniRef50_D1RJ36 MarC family integral membra... 105 1e-21 1 20.9% 1:196 5:221 IQAIFFSFAALFPIVNPVGASIVFLTLVKGSSRQQINALAIKISIYTVVMLLLVLVVGSLILSIFGITVPIVLISGGLLLTQVGWQMLYKPHDESTGLSSSadPRAFYPLTLPVTAGPTCIAITIALGAHGAQNVWEssIGIILIGLSVFFCYRYSYYIFDKLKDAGKNVVMSLAAFLNICIGLQIIWRGIEMLIP-
218 UniRef50_A7I7F8 Multiple antibiotic resista... 103 2e-21 1 24.2% 2:195 13:222 -TFFVTSLAALFAIINPVGNIPFFIMYTSEisPRTRQAVAVLLGPVIFVTVLLCMFFGSAVLSFFGVSMPAFEIAGAIILMIIALSMISGTRTEQVHAATSSEtkIFIPLIFPIYIGGGTIAVSVLYGNDagGFLAAAIGVTAIICIIIIACNLASDAITRVLGKQGLEIVARLVGVLLLGLAVQMFATGAGEMV--
219 UniRef50_A8Z5R7 MarC family integral membra... 103 4e-21 1 25.7% 9:195 1:180 --------MVLFSIIDVIGNAPIIIGYKNKGDIINPNQV----TLVSLGIFLFFIFLGNFILNTFGIDIYTFSLAGSIILFFISLEMILGIEFYKRDKSTSAQ-VSIIPISFPLIAGPGSVTTLMSLKKNY--DMQTILISLILNMIIVFFVIKKIDYIENNISNDNLNIIKKVFGIILLSYSIKLFGRNICNIF--
220 UniRef50_UPI000038253B COG2095: Multiple antibioti... 102 5e-21 1 24.3% 1:152 11:170 LTSFLLALSGLFSIVNPVGSALIFAQVTATRSQGERAELSRRIGFYAALVMLAALWAGAPILNFFGVSLAALRIAGGLFVAASAWTLLSAPETREARKHAEaaEIAFFPLTLPFTTGPGTIAVAIALGANRPSEPADLAAFFVGASLAALAI---------------------------------------------
221 UniRef50_A1RTR6 Multiple antibiotic resista... 102 7e-21 1 25.1% 3:197 5:194 --EFLGLVGQLYAIMNPIGKLAV-VGPLAVERPAYVRKITTVVIAVVYILAAIFAVSGGFILSAFGVSINSFRIAGGIVLMTISVTTLLSGSYVGR--IEITEEHAVVPLATPLIVGPGTITALIVMSSIYGPLITLFIA--LTASTAVAITLIVGIRAVKYIGATPLRLVGRFMSLIIASVATEMILTGIRNYTQS
222 UniRef50_B3ET88 Putative uncharacterized pr... 101 1e-20 1 26.7% 1:187 13:191 IKKFLTAFFILFAVIDVLGCTAIIINMRNKIGYIH----ARKTATVAGVIMVTFLFLGQTILDLFSIDMSSFIIAGSIILFLLGLEMCLNISIFKTDT--DANSSSIVPLAFPIIAGTGTLSTLLILRAECET--INVLLASLVNLVLIFLVLKYSEWIEAKLGRLGVSIIHKMMGIILIAIAIKRF----------
223 UniRef50_A5GU87 Uncharacterized conserved m... 100 2e-20 1 20.6% 2:195 4:212 -SSFQHYLIGLLAIGNNVSALGAFLLHTQGMPRAKVKRLILMSGLACLITLVLFMVVGTRILDFFGISVSAFQIAGGLLLGGVGLEMMNSRTPLPTgsDAQFYSAAVVPIGIPLTIGAGTLSAVVLFAETasGTALNLLGAILILVLVNTAIFRFSSRIMAWLGEVGVTIFIKLMGLFTLAIGVEFLTKGLGAIY--
224 UniRef50_C7LK11 MarC family integral membra... 100 2e-20 1 23.9% 1:197 8:197 IKLFFTCFLILFSIIDIIGNAPIIIGYKKKGNIINTKKI----TLVSMLIFLFFFFLGDFFLNSFGIDLYSFSLAGSIILFLVSLEMIFEIDFSKLEKKSNI-EISIIPISFPLIAGPGSVTTLMSLKTNY--DIKTIMLSLILNMIFVFFVIKNIDFIEKKISKSNLYIIKKLFGIILLSFSIKVFGRNVCNIFPN
225 UniRef50_Q4C088 Multiple antibiotic resista... 99 6e-20 1 18.9% 8:192 83:274 -------TIILFMTIGPIKIIPVFARLTQNASKQVIIKLATRSFALSTLSILTVALASENILNKYIISLSSLIVAAGIVLFLISLKMLLQQYDNQKNnpENPLTALISPLTFPTILTPQGIALVMiiAQRLDNNVDKILGLIMVVMILNLLSMLDARQILTVLQPILLQILNLILSIIQLALAISFMFSGIT-----
226 UniRef50_Q89Z73 Multiple antibiotic resista... 99 6e-20 1 18.6% 9:196 15:220 --------MALFPVINPLGNGFVVNGFFADLDPSQRKTAIQKLTINFIMIGVGTLLIGHLFLLIFGLAIPVIQLGGGILICKTAIELLGDSNSSDKEGTSQNVDSffYPITFPISIGPGSISVIFTLMASagINYLVIALVIICMAGILYVFLSQGQRIIQKLGPVGNQIINKLVAFFTFCIGIQISVTGISQIFH-
227 UniRef50_B8HLY6 Multiple antibiotic resista... 99 7e-20 1 18.3% 3:188 7:202 --TLSYVFTIFFLTLGPVKTISAFFRLTREANPKFRQRVALQAALISTAICLFIAFIGHNVLAKWGVSLEALRLAGGLILLLFALkmMQPQPSaaDTPLPDTLKLAITPLSTPVIVTPYGVVAimVIAQGYAVLQVQILGIVFLIMLLNYLGMIFADKIMNIIGMPILQLIGWIFAVMQSALAIDIML---------
228 UniRef50_C9L1U4 MarC family integral membra... 98 2e-19 1 20.0% 2:196 23:209 -QQMVSAFIVLFAVI----DIIGSIPIIINLKERGKDVNAMKATVISFVLLIGFFYAGDMMLKLFHVDIESFAVAGAFVIFLMSLEMIL--DIEIFKNQGPIKEATLVPLVFPLLAGAGAFTTLLSLRAEYAS--VNIIIALVLNMIWVYFVVSMTGRVERFLGKGGIYIIRKFFGIILLAISVRLFTANITLLIE-
229 UniRef50_C6HYD3 Multiple antibiotic resista... 97 2e-19 1 25.6% 1:195 1:196 MHTFWSVFLPLFVAIDPPGVLSIFFSLTQGVDIAQKRRTARSAVLTASLTVLFFDVFGTRLLDFLGLTLWDFTLAGGLLLLVLSVSDLLKNQDPETAGRPPGPFIGtvPLGIPIIAGPATLTTSLI--ASKSASLAWALTALAANMAILLAVLLAADRITRLLGAPLSAAVGKIFSLLLAAIAIHLIHRGIDGLL--
230 UniRef50_A6C262 Putative uncharacterized pr... 97 5e-19 1 19.6% 1:194 1:199 MNDVFNSTALLLTLLNPFLVIIYLVDVVQKLEQKQFRHVLMRAGLITSAIFCSFVVLGDKIfgVMQVEFASFQIFGGIVFLLIGIQFVFKGPVVIEALRGESSNISAS-IAMPVLIGPGTISACVLIGKRHEPLVACTIVVISvvCLATILVLKFIHDMVnaLIDRYIEIMGRITALYVGTVSIDMIMQGLRTW---
231 UniRef50_D2PCH4 Multiple antibiotic resista... 97 5e-19 1 28.4% 1:194 4:199 LVSIPEIAFKLYAIMDPLSILPYLIALYEEFNRNSQNKISwkLSIAVAVLLLFFSILGGPLLAFLGISVSALEIGGGIILVYLGVDTL-GGFQQLKFLSSKIEEAIITPIATPLIVGPGTMTGLITLS--VSNNLIILILGSLLAALLVYLSLLLGPIIIRVLGNTGTVAVGRFMAIIIAAFGVQLIIDGISQI---
232 UniRef50_B1WP37 Putative uncharacterized pr... 96 5e-19 1 15.3% 6:181 98:279 -----NIFIIFFVTLGPIKIIPTFIKLTQNADDDLRKSLALNGAGLATIVIVLVVLIGGNILTRWTVSMSALLMAAGIMLFLASLQAVMSQYKGSAENeePSMKLLINPLTFPTILPPYGIALALILmnRISDRPFIVPVMLILVMMLNLLAMLFARPILKTIKLPTLRIAGLVLGVMQLA----------------
233 UniRef50_C5A3J5 Multiple antibiotic resista... 96 6e-19 1 20.1% 2:195 5:197 -STILSSALLMLIMIDPSDKILLVSFLREDFHIEDIKALIVRANLIGFLLLASFAVAGQIIleIFHIDINALKVAGGFVLFKIGLEALEGGGMFTLKRERDILALAAVPVAMPLIAGPAAITAVITLTAEYGYLVS--LSATAIAIAVVALSMFVALYMMKSVNKTFLSVTIRIIGLFIMAIGAQMMVEGVVGIY--
234 UniRef50_B3T2F3 Putative MarC family integr... 95 1e-18 1 28.3% 51:195 1:155 --------------------------------------------------MITFAYAGRYLLDAIGVSLDSLKIAGGIILMILAIDILFEKRKTRREKRVEedDIIVFPIAIPFIAGPAALTTIILLIGNYTInqIPVILALIAALVVSLILMIGANFIVKFLPKQILHATARVMAFILAALATQFIIDGIKASF--
235 UniRef50_Q467G3 Multiple antibiotic resista... 95 1e-18 1 23.4% 51:195 1:153 --------------------------------------------------MPFFAVTSNIILELFSISVDSLRVVGEILLFSIAFDMMHAktEEDISQSQEREDIWVFPIGLPLLIGPGEISTVIVLMGSTEnhKIIILISIIFTFILCLYIFLLSRRIHKFIGYNGMLVFTKLMGLLLAALAVNLTSAGLKNIF--
236 UniRef50_A6T440 Multiple antibiotic transpo... 94 2e-18 1 16.8% 2:192 3:198 -EAYLRSFALFFALFNPFLMSIYLLDLIRGLPTPTFARVLIRGSVISACVFVLFAWGGEAFfdYLQVRFASFQIFGGIVFLLIGLRYVFSGAAAIESLRDNPTAMAGS-IAMPIMIGPGTVSAAVVIGTRLpgGAAVVIVGTLILTVSILVAMKVAHDKLkaMTDRYIDLVGRMSALLIGTIAIDMILTGLQ-----
237 UniRef50_B5IJ45 Putative membrane efflux pr... 93 5e-18 1 20.4% 1:196 1:200 MEDLNRSVITLLALINPVICAVMLLERTPGVPHRRRLLLIGNVVLRTGLILLVSAAIGPQLLKRLGISLDVFQIVGGVVITSIGYGmsPAPAAATGQESGSPENASLDPIVL-FAASPGTISTVLALSVMHGPDQGLlsLAVLIALAITAVVMAVMVLRPGASTRSNSSLVSRFLGLILIAMGLQFVLTNLRTFFQ-
238 UniRef50_Q5WGH6 Putative uncharacterized pr... 92 8e-18 1 17.8% 1:197 2:191 VSFFIHAFVSIFAILYPIGNLSVRLGLAHIKGDTQRIHKAAKAILVVLGALTTLLLLEQWLLLLYNISIEAFTIGCGLCLLVIGCKLLQGKTRYRSKQKTIFATVA----------SQGAAGATMCLTANQNHRWFYVPITFLavLVLSLLPLLVANWLRGRTGQKGLSLVKRATGVALTVIAIEMVVMGFADILPS
239 UniRef50_B1TBT7 Multiple antibiotic resista... 92 9e-18 1 26.5% 17:197 21:209 ----------------PPVAIPMYAAVTGHFPDATQRQIAFRLFAWIATLMVGAVWGGQFLLRMLGLTLGALTLTGGLVLCLWSIPMMRGTANDERSGGDTRLEYaaVPLIFPLSIGSAVMSLVITTATRFHTPVDLLAlaCILHAGVIGLTYACSASWCRRLGEIGRTLIERLSGIVLTAIAFQMLAQGVRELLPG
240 UniRef50_A8M8X4 Multiple antibiotic resista... 92 9e-18 1 27.6% 5:196 10:195 ----LVAAVQLYAIIDPLGAIPLLVSV--PDYEKMMNKFLRLVAVTVPLLLLLFAFAGPFIFYVFSININDFRVAGGIILLIIAIDVLREGTPKTMG--INPEDYVIVPIITPMLVGPGAITSVMVMVTYY--NIFSVITAVLIASLATYITMKYSVYLVKLIGNNTLKIFARFFSLIIASWAIQLIASGIINIVK-
241 UniRef50_D2ASF4 Putative uncharacterized pr... 91 2e-17 1 18.8% 5:195 6:215 ----LILFLALFGLYSPVAALASYLPIVRPYSHGQVNRLALGLAFNVAVFVLAALWVGEPLLKLLGISTAALTATGGIALAYASIPLMRGKAGapTEPAPDPKSILYTPLTFPLTVGGTTFAFGVAASASAAGTQDKIALSIAALCfvTGLTLYLSGHVQRRISLKGAMLLDRVAGILLTAIAVILLANGFTDLV--
242 UniRef50_A2SQL2 Multiple antibiotic resista... 90 3e-17 1 25.9% 38:195 3:167 -------------------------------------RQAFVATGVAGVLMLTFLIFNNLLFDLLGIELESFKVAGGIILFILGLQIVLghKSLESSDRIGKKSMAGVIIGTPVMCGPGTITTVMILGAQ--DGIILTLVAVILALFCIWLILIFSAQIKKLLGETVLVILSKIVGLLLTAIAVHTIWTGILGLI--
243 UniRef50_D0SWE6 MarC family integral membra... 90 4e-17 1 20.9% 1:196 1:201 MSESLNAFALFFSLLNPFLMSIYMLGIIRNSDAKVFNMALIQGSLISFIVFIIFAKTGEAFFnvLHVRFESFQIFGGIIFLVIGYRYVFEGADTIGVMRGAPSHLAGT-IAMPFMIGPGTISASVITGIQLSLMQTILVIFSTLFLTCSLLILmlHDHLQHKYsdLYVDIVGRVAALLIGTIAIDMIVTGVTGILE-
244 UniRef50_O57953 UPF0056 membrane protein PH... 90 5e-17 1 20.0% 1:195 2:195 LKEILSSALLMLIMIDPSDKILLVSLLREDFHIEDVKSLIIRANLIGFILLLLFAVAGKIIldIFHIELDALRVAGGFVLFKIGLEALEGGGMVTIKREKNILALAAVPVATPLIAGPAAITAAITLTAEHG--IIVSIVGTLIAIAITAALMMIALYLMRGISKTALSVTIRIIGLFIMAIGAQMMITGAGGIV--
245 UniRef50_D0ZDR8 Membrane efflux protein n=1... 89 6e-17 1 20.5% 1:195 5:208 LIHFLLTYVTFLSMFCPPATITAATILLGQTPPHTLRQLAWKVALEYVAVMLVAIWIGNYLLMALGLNAHALTATGGAALLFQGWPLMTKGTKAepDARPNVQDMVLVPLLFPLTIGGGTIAVGISLASHDGsgLLQLSAVILLMAPTIALTFLAVGPLHGRLSSGAIDAMARIAGIVLVTLSLQLLASGLTQLV--
246 UniRef50_C6B1S6 Multiple antibiotic resista... 87 5e-16 1 20.0% 15:194 22:206 --------------MGPKIALVPFLEKTHAFDTQTKVRIGRQMVMIAVVTALILFATGALLMRLLHITGGAVAVAGGIILALIAIKMASGPIEKPHDDIAAPVDpaVFPLAVPYLLNPVGITVIIIASGEVVssAILVIGLILIVGALDYLVFTNIDKLAKRMKPVTMIVSEVVFGILLTAVAVQLIVVGLGNL---
247 UniRef50_B4B2T8 Multiple antibiotic resista... 85 1e-15 1 23.2% 1:194 1:201 MLKLSSIFILLFITLGPLKTIIPFVELTAHSDEKLCRRVALRATFASTLVVLILGLLGPLILENWGVSLPAVSITGGIILFVGSLQVMMKPSESSGNKGVAPETLsiSRLVIPTIVTpaAILALMVLSEKNQQLWLQIIGLLLLVMFLNLLIMLTARKLLAFLTVAGLRVIAWVFAVLQASLGAQVIINALRKL---
248 UniRef50_B2S770 Multiple antibiotic resista... 80 3e-14 1 20.7% 10:197 13:204 ---------LLFNMMGPIGLMPIFAAMTVQMDKPTRNSVAARAAIFAALGILIAIFIGDPILRSWGISKPALILAAGVILTLSSIrlMPPAAPSQPAAAGDPKALAIRPLAFPTIVSPQGVGVLIIFVasSLSSTITILTVAGVIVLLDYGAMRIAHWFMATVGMVPLLVLGAVFGVLQVALGIEMMLSGLLLVLNS
249 UniRef50_Q12GH3 Multiple antibiotic resista... 77 3e-13 1 35.0% 45:167 60:182 --------------------------------------------VTARIVLLIFMVAGDRLLHAMRLTDASFEIAGGVILFLMAMGMAFPGMGVSLADSGHGGEPMLVPPAIPVITGPSALATVLLLAARQPDRGWTWAAAIGLLLSAMAVDKLISGLRRAFPGVTG------------------------------
250 UniRef50_A8U398 Multiple antibiotic resista... 72 1e-11 1 22.6% 92:197 10:116 -------------------------------------------------------------------------------------------TATATYGDAQAIKVGVVPLGIPLMAGPGSFTAVILEshSHSGGSLSVSLTIIGVAAVMWVLYLLAVPIARILGPIGLNIITRLFGLVVTAIGVEIIVRGIQTHVAS
251 UniRef50_Q0EYM7 Putative uncharacterized pr... 72 1e-11 1 20.2% 23:195 4:182 ----------------------YLLDLIQDLDRGTFFKVLFRATLISGSVFLVFAWGGDAIfdILQVQFSSFLIFGGIVIFIIALQMMFTGSDAIKKMRGGDPAHLSGSIAMPFMIGPGTISASVITGTTLSYPLALAAITLSLIlvLMLMVLKYAFDIIKvlLERYIDITGRASALLTGTIGVQMILQGIHKAL--
252 UniRef50_Q255K2 Multiple antibiotic resista... 67 3e-10 1 25.6% 1:195 4:201 MYLLFPQACILLLAADALTNVLALNCVLSNYSRKKRLSLLIRESLFALVSMFALYAAALGTLYVLKTPPCAIQVVGGIAVTLAGMRAILNLNRENTWQGFASTSSlvTPIALPLMIGPSWLAacILIGKRYSFTSISLILFLSWALISLTTIILQVFIGVGKEKTKVLLATQTVLGLFATIVGTQLLMSGLQLAF--
253 UniRef50_Q92Z96 Putative uncharacterized pr... 62 1e-08 1 18.1% 51:194 7:151 --------------------------------------------------LAIAGLLGRTMLENFEISLPVLAMTGGIILFLVALRTVLHQSSstEPGQPSDLRLALTPLAFP------TILAVIVFATLAGGRQAevAAIVLLILAMDWAAMIFAESILRWIG-TSLQVLAVVLGVTQAALGLQIILHSLSTV---
254 UniRef50_D1BGR1 Cytochrome c biogenesis pro... 59 7e-08 1 18.3% 34:186 121:298 ---------------------------------ARRKSLRPYLVISGLVVSffFTLLGSLILNALGLPQDLLRWVGLSLLAIIGVGMIVPRLEeaRRGSARQDRGAfvPCAGPVLA---AITVAGATGNIGADTVALTVSFAVGAAIPLLIFALAGRRVAERVGakGIRIFGGVT-MILLAIGLAF-----------
255 UniRef50_D1K837 MarC family integral membra... 52 1e-05 1 18.0% 46:106 9:69 ---------------------------------------------ISFITLLAFTFSGQFLFKFFSISTNNFRIAASFIILKIGYDMLQARFTNTKLKNKEIKTYA-------------------------------------------------------------------------------------------
256 UniRef50_A6FJM2 Putative uncharacterized pr... 48 1e-04 1 18.5% 2:66 6:70 -EHALTVFMAFFAIMNPIANTTVFAGLTGSMGKSEQVKIAVKSLTITFVIIVLFSILGKSIFHLFG-----------------------------------------------------------------------------------------------------------------------------------
257 UniRef50_A2V4T5 Putative uncharacterized pr... 45 0.001 1 28.9% 158:195 29:66 -------------------------------------------------------------------------------------------------------------------------------------------------------------PICKFMGKTGIDALTRIMGFLLVSMGMQFMINAVKDLL--
258 UniRef50_Q8ZY52 Putative uncharacterized pr... 44 0.002 1 28.4% 3:76 5:77 --EFLGLVGQLYAIMNPIGKLAI-VGPLAVEKPTYVRKITVVVIIAVYILSLIFALSGGLILAAFGVSLDSFRIAG-------------------------------------------------------------------------------------------------------------------------
259 UniRef50_D0WLW3 Protein DipZ n=1 Tax=Actino... 44 0.003 1 14.6% 2:158 4:180 -QILIGLFGGLITGVSplPMLPifLAGATGASSDGkrKYPLLVTLGLVVSFTAVTLLGSTVLSLLGLPQDFIRWAGVAFLALIGVSLMIPKVEEWLEKPFARIRmaYVPCAGPVLA---AISVAGS-TGRVGAETAALAISFAVGVAVPLFFFALAGR---------------------------------------
260 UniRef50_B4V0W4 Integral membrane C-type cy... 41 0.018 1 16.3% 43:195 166:329 ------------------------------------------AVVAGLVVSffFTLLGVTIISALGLPQDILRYLGLGLLVMIGLGLILPPVERLLEKpvNKEGSAfvPCAGPVLA---AITVA-GARGEISSGIVALTLSFALGTAIPLLVFALAG---RRVSARVAAFRTRARGLRIAA-GTLMIVLAFALAF--
261 UniRef50_A7BB75 Putative uncharacterized pr... 41 0.019 1 20.2% 38:156 80:212 -------------------------------------SVTRRPVLIVLGLVTSFmvAGSALLSLLNLPQALIRWTGIVLLMAVGIGMIIPKIMEVLERPFTRLApaFVPCAGPVL------TSIIVASSSGQITWHIVGLAISFAIGVSIPLMIVA-----------------------------------------
262 UniRef50_P59960 Protein dipZ n=22 Tax=Actin... 41 0.023 1 16.7% 34:165 162:315 ---------------------------------AVRRKRALSATlvIGGLVLSFglLGSALLSVLHLPQDAIRWAALVALVAIGAGLIFPRFEQLLEKPFsaLGVLYVPCAGPILA---AIVVAGATATIGLGTVVLTATFALGAALPLLFFALAGQRIAERVGA--------------------------------
263 UniRef50_C4XRQ9 Thiol:disulfide interchange... 40 0.068 1 18.5% 24:180 402:577 -----------------------LLAISGEEGRQERRRILREHNFFFALGIVTYFLCLSLILGAFGmqSPSLAIVAAVVLFALALSLfrGHTRRGAFLTGALATLLATPCSGPFLGG--VLAWTLL---QPQHVIMTVFAAIGLGMASPYGVLAIWPRLVRLLPRPgmQSLERVMAFLLA-----------------
264 UniRef50_Q3DHU8 Putative membrane protein (... 40 0.069 1 32.6% 9:51 1:43 --------MAFFAIMNPISNLPAFMALVADDDQKISRRIAAKGVLLAFVIM--------------------------------------------------------------------------------------------------------------------------------------------------
consensus/100% .....................................................................................................................................................................................................
consensus/90% ..........hh.hhss...h.hhh.hh.t..........h...h..hhhhhh.hhhGt.hhthhtlt..shthsuuhllhhhuhthh...............t..hhPhshPhhhuPushshhh.h.tt.......hhh.hhh..hh.hhhh..s..h.thht..h..hh.ph.uhhh..huhthhh.sh......
consensus/80% ...hh..hh.hh.hhsPhs.hshhhshhtt.s.ttp.thhhh.shhshhlhhhhhhhGt.lhthhslshsshpluGGlllhhhuhphl.st.tt..tt..t..p..hhPluhPhhsGPuslsshhhh.tp.....h.hhhshhhhhhhhhhhhh.ut.l.phlu..sh.hht+lhuhllhsluhphhhtGh.th...
consensus/70% ...hh.hhhhlhslhsPhushslahshstths.tpppphshpsslhshhlhhhhhhhGphllphhulolsuhpluGGllLhhhuhphl.sttptttttttpttphulhPluhPllsGPGslsshlhhssph.t.hhhhhhulhhshhhshhhhhhuthl.chlGttuhthlsRlhGhllhslulphhhsGltthh.
|
MView 1.51.1, Copyright © 1997-2009 Nigel P. Brown